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ABSTRACT
The effect of self-generated hypoxia on the expression of target genes coding for electron
transport related products in mycobabcterium tuberculosis
By Prathna Harrikaran Ramchandra
Supervisor: Professor AW Sturm
The work presented here aims at identifying whether the genes identified in the genome of
Mycobacterium tuberculosis that code for products involved in anaerobic metabolism are active or
inactivated genes. The study consists of three distinct parts.
In part one, serial dilutions of sputum of patients with pulmonary tuberculosis (PTB) were grown
on agar surface and in high columns of un-agitated broth. The highest dilution from which
mycobacteria was grown was for all patients significantly higher in the broth cultures than on the
plates suggesting the presence of anaerobically metabolizing mycobacteria in the lungs of patients
with PTB.
Part two of the study identified gene expression by measuring the concentration of transcripts for 5
genes involved in aerobic or anaerobic pathways. This was done over a period of 15 weeks using
un-agitated broth cultures (the Wayne method). Undulating patterns of gene expression were found
with the genes coding for anaerobic metabolic pathway components expressed at higher levels than
those coding for aerobic pathway components while the cultures grew older.
Part three aimed at measuring transcription products of the same set of genes directly in sputum
specimens. Although quantitation at bacterial cell level in the sputum could not be achieved,
expression of all genes was established with on average larger quantities of transcripts of genes
coding for the anaerobic pathway components.
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SUMMARY OF KEY CONCEPTS
Summary of Key Concepts and Definitions
H37Rv Genome
Cole and colleagues (1998) published the complete genome of M. tuberculosis H37Rv. This
exercise revealed many unknown features that the bacterium could potentially use.
Dormancy Regulon
Voskuil and colleagues reported a set of approximately 48 genes that allow M. tuberculosis to
adjust to environmental changes.
Wayne Model
This is a culture model for growth of M. tuberculosis in liquid culture medium that allows for the
formation of a self-generated oxygen gradient. The tubes are left undisturbed during incubation and
remain sealed. There is no oxygen circulating in these tubes and the cells undergo what is
described as an orderly shut-down.
Non-Replicating Persistence
When grown under gradual oxygen depletion in broth, M. tuberculosis survives in the culture
media without increasing in number (i.e. cell division ceases). This happens in 2 phases known as
NRP-1(micro-aerophilic) and NRP-2 (anaerobic).
xii
Anaerobiosis
The occurrence of metabolic processes in the abscence of molecular oxygen is referred to as a state
of anaerobiosis.
Hypoxia
This refers to a diminished availability of oxygen.
PCR definitions Threshold: Usually 10X the standard deviation of Rn for the early PCR cycles
(background activity). The threshold should be set in the region associated with an exponential
growth of PCR product (which may be easier in the log-view of the amplification plot) and not as
high as the linear or plateau sections of the curve. It should be above the highest baseline signal
level. It is assigned for each run to calculate the Ct.
Ct (threshold cycle): Threshold cycle reflects the cycle number at which the fluorescence
generated within a reaction crosses the threshold. It is inversely correlated to the logarithm of the
initial copy number. The Ct value assigned to a particular well thus reflects the point during the
reaction at which a sufficient number of amplicons have accumulated. This is also called the
crossing point (Cp) in LightCycler terminology.
Rn (normalized reporter signal): The fluorescence emission intensity of the reporter dye divided
by the fluorescence emission intensity of the passive reference dye. Rn+ is the Rn value of a
reaction containing all components, including the template and Rn– is the Rn value of the negative
xiii
control. The Rn– value can be obtained from the early cycles of a real-time PCR run (those cycles
prior to a significant increase in fluorescence), or a reaction that does not contain any template.
ROX: (6-carboxy-X-rhodamine) Used as passive reference dye for normalization of reporter
signal. The emission recorded from ROX during the baseline cycles (usually 3 to 15) is used to
normalize the emission recorded from the reporter due to amplification in later cycles. The use of
ROX improves the results by compensating for small fluorescent fluctuations such as bubbles
and well-to-well variations that may occur in the plate.
FAM: (6-carboxy fluorescein) A reporter dye at the 5' end of a TaqMan® probe.
xiv
INTRODUCTION
Over the last few decades, Mycobacterium tuberculosis has developed mechanisms of resistance
against most of the available anti-tuberculosis drugs. For many years these drug resistant strains
were thought to have limited ability to spread within communities. Currently, a limited number of
successful strains have acquired the ability to be transmitted as resistant phenotype. That includes
multi-drug resistant (MDR) as well as extensively drug resistant (XDR) strains (Pillay and Sturm,
2007; Filliol, et al 2003). There is therefore an urgent need for the development of new drugs for
the treatment of patients infected with MDR or XDR M. tuberculosis. The study of metabolic
pathways in M. tuberculosis can consequently lead to the identification of new drug targets.
M. tuberculosis has been historically characterized as a strictly aerobic organism. This has
hampered the understanding of the persistence and latency of tuberculosis. Reports disputing the
aerobic nature of the organism arose as early as 1933. In the 1970s the concept of M. tuberculosis
as a facultative species was reintroduced by Wayne et al (1976). When M. tuberculosis is grown in
liquid medium exposed to air, and the culture is left undisturbed, equilibrium is established
between the rate of replication, oxygen diffusion and the rate of bacilli settling at the bottom of the
tube. In addition, actively replicating bacilli die rapidly when they are abruptly derived of oxygen
(Wayne and Lin, 1982). They have however been shown to shift into a stage of dormancy when
they are allowed to adapt to gradually decreasing oxygen (Wayne, 1976). We therefore chose to
use this liquid culture model, to investigate the role of selected genes in adaptation of M.
tuberculosis under stress conditions.
xv
This study provides novel insights into the manner of gene expression patterns in M. tuberculosis,
leading to a better understanding of its persistence mechanisms. We provide insight into the
simultaneous occurrence of the forward and reverse reactions of the conversion of fumarate
providing new information regarding the operation of the forward and reverse cycles of the TCA.
We also report on the expression of a cytochrome b reductase component, under anaerobic
conditions, despite reports of this being an aerobic component. In addition we provide preliminary
evidence based on gene transcript detection, that cells present in vivo are predominantly anaerobic
in nature. In addition we provide the first report of the expression of the menB gene in vivo and in
vitro. Since this represents a critical pathway that occurs in bacteria only, it proves to be an
attractive drug target, having already been theoretically marked as such. We further demonstrate
the up regulation of the ferredoxin gene fdxA in oxygen depleted cultures and the detection of its
transcripts in sputum specimens of patients with pulmonary tuberculosis. This justifies further





Section 1: Literature Review
An Introduction to tuberculosis
1.1. Preamble
“The struggle against tuberculosis is not dictated from above, and has not always developed in
harmony with the rules of science, but it has originated in the people itself, which have finally
correctly recognized its mortal enemy. It surges forward with elemental power, sometimes in a
rather wild and disorganized fashion, but gradually more and more finding the right paths.”
(Robert Koch, 1905)
Robert Koch, known as the father of bacteriology, identified and described the infectious agent
causing tuberculosis, Mycobacterium tuberculosis, as early as 1882 (Kaufmann, 2003). His
presentation on 24 March of that year facilitated experiments to elucidate the nature of the
ancient disease and to develop remedies against the infection. In 1890 he reported on a
glycerine extract of the tubercle bacilli as such a "remedy" (a vaccine) for tuberculosis. He
named the extract 'tuberculin', a term still widely used for Purified Protein Derivative (PPD)
which is derived from Koch’s extract (Parekh, 2009). Although tuberculin was not effective as
a therapeutic or prophylactic vaccine, it was later adapted by von Pirquet in a test to diagnose
pre-symptomatic tuberculosis. Mantoux modified von Pirquet's test in 1907 and the Mantoux
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test, in which tuberculin is injected in the skin, became the most frequently used diagnostic test
for sub-clinical tuberculosis for decades to come. This test is still used for this purpose.
Koch opened his Nobel Lecture in 1905 by indicating the difficulties and hurdles that were still
faced by tuberculosis researchers in trying to neutralize the disease and indeed, progress has
been very slow for at least a century
This is corroborated by the fact that M. tuberculosis is currently the leading bacterial cause of
human mortality in the world (Rao and Vijaya, 1995). It claims millions of lives per year and is
responsible for more deaths annually than any other single bacterial pathogen (Bloom and
Murray 1992; Kochi, 1991). It is a facultative intracellular organism and its entry of, its
subsequent replication in, and its ability to avoid destruction by the macrophage, are critical to
its virulence. Since M. tuberculosis is capable of residing within host cells for a long period of
time, it must have mechanisms to overcome nutrient limitations.
Hippocrates described a disease that he named "phthisis” which means “consumption”, since it
was characterized by wasting. He reported this disease to be the most widespread and fatal
disease of his time. Later observations make it likely that “phthisis” was indeed tuberculosis. It
is often stated that tuberculosis is as old as mankind. The presence of abnormalities
characteristic of tuberculosis in the skulls and spines of Egyptian mummies, provides evidence
that tuberculosis has been plaguing humans for at least 4000 years. Salo and colleagues (1994)
reported the detection of insertion element DNA, unique to M. tuberculosis in mummified
human remains found in Peru. Fletcher and colleagues reported in 2003 similar findings in
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naturally mummified remains of a mother and two daughters which were located in an 18th
century Hungarian crypt.
More than a century after Koch discovered M. tuberculosis, the World Health )Organization
still reports alarming statistics: The World Health Organization (WHO) estimates that the
largest number of new TB cases in 2008 occurred in the South-East Asia Region, which
accounted for 35% of incident cases globally. However, the estimated incidence rate in sub-
Saharan Africa is nearly twice that of the South-East Asia Region, at nearly 350 cases per 100
000 population’’ (World Health Organisation, 2010).
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1.2. Mycobacterial Physiology
Mycobacterium tuberculosis is a non-motile rod-shaped bacterium related to the Actinomycetes.
Its generation time is 15-20 hours, making it one of the slowest replicators amongst pathogenic
bacteria. This characteristic may have a role in its pathogenesis. Many other chronic diseases
are caused by bacteria with long generation times, for example, M. leprae causes leprosy,
Treponema pallidum causes syphilis, and Borrelia burgdorferi causes Lyme disease (Orme
1988 (b)). The cell wall structure of M. tuberculosis is distinctive among prokaryotes and it is a
major determinant of virulence for the bacterium.
The insoluble cell wall core (formed after the removal of soluble proteins, lipids and
carbohydrates), is chemically composed of three covalently linked macromolecules: highly
cross-linked peptidoglycan, arabinogalactan (AG), mycolic acids (Cole, et al, 1998). Mycolic
acids are high-molecular-weight fatty acids consisting of a short β-hydroxy chain with a longer 
α-alkyl side chain. They are found in the genera Mycobacterium, Nocardia, Corynebacterium
and Rhodococcus (Brennan and Nikaido, 1995). The outer leaflet, consisting of covalently
linked arabinogalactan, mycolic acids and other lipids, constitutes a very hydrophobic barrier.
These components make up a significant fraction of the dry weight of the mycobacterial cell
envelope.
Mycolic acids are thought to play a significant role in virulence in M. tuberculosis. They protect
extracellular mycobacteria from complement deposition and phagocytosis. They also confer
intrinsic resistance to certain antimicrobial drugs (Nikaido, 2001). Hoffmann and colleagues
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reported recently (2008) the structural nature of the mycobacterial cell wall. They advise that
the structure of the mycobacterial outer layer requires revision. They used cryo-electron
tomography and vitreous sections to reveal the lipid bilayer structure. They report that proof of
the structure of the mycobacterial outer layer will have an impact on the design and
interpretation of experiments aimed at elucidating the translocation pathways for nutrients,
lipids, proteins, and anti-mycobacterial drugs across the cell envelope.
Serpentine cording is a phenomenon that was found to be distinctive in virulent mycobacteria
and was thought to be the result of the production of cord factor (Bloch, 1950). This “cord
factor” was later found to be a group of mycolic acid-containing glycolipids (Indrigo, 2003).
Trehalose-6, 6’ -dimycolate (TDM) is the most prominent and best-studied representative of
this class of molecules (i.e. cord factor molecules). Indrigo and colleagues (2003) further
reported TDM as having a range of biological activities including immune-modulation. They
reported that in murine models, immune responses to purified TDM mimic aspects of natural M.
tuberculosis infection, including production of pro-inflammatory cytokines (IL-1b, IL-6 and
TNF-α), development of granulomas, pro-coagulant activity and decreased cortisol in the blood 
(Actor et al., 2000; Behling et al., 1993; Perez et al., 2000). Additionally, TDM is reported to
prevent the fusion of phospholipid vesicles (Crowe et al, 1994; Indrigo et al, 2003; Spargo et al,
1991). This implies that TDM may contribute to intracellular survival of M. tuberculosis by
inhibiting phagosome–lysosome fusion after invasion of macrophages.
The high concentration of lipids in the cell wall of M. tuberculosis has been associated with
protective properties of the bacterium like impermeability to stains and dyes, resistance to many
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antibiotics, resistance to killing by acidic and alkaline compounds, resistance to lysis via
activation of the alternative complement pathway, resistance to lethal oxidants and resistance to
elimination from macrophages (Indrigo, 2003).
Macrophages are fundamental for the initiation of immune responses. Through a variety of cell
surface receptors, macrophages internalize microbes into phagosomes that undergo maturational
events allowing phagosome-lysosome fusion that expose the microbes to acid, lytic enzymes,
oxygenated lipids and fatty acids (Nathan and Shiloh, 2000). The ability to persist in
macrophages is not unique to M. tuberculosis. This ability to conceal itself within macrophages
confers a degree of protection from interactions with other immune components as well as
antimicrobial agents.
Lipoarabinomannan (LAM) is a phosphatidylinositol anchored lipoglycan composed of a
mannan core with oligoarabinosyl-containing side-chains with diverse biological activities
(Hunter and Brennan, 1990). The tubercle bacillus can bind directly to mannose receptors on
macrophages via the cell wall- associated mannosylated glycolipid, LAM, or indirectly via
complement receptors or Fc receptors (Chatterjee and Khoo, 1998). M. tuberculosis is known
to impede the toxic effects of reactive oxygen intermediates produced in the process of
phagocytosis by two mechanisms. Firstly, compounds including glycolipids, sulfatides and
LAM down regulate the oxidative cytotoxic mechanism. Secondly, macrophage uptake via
complement receptors may bypass the activation of a respiratory burst (Hunter and Brennan,
1990; Chatterjee and Khoo, 1998).
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The antigen 85 complex is composed of a group of proteins secreted by M. tuberculosis that
bind fibronectin. It is coded for by the fbpABC genes. The observation that live M. tuberculosis
elicits protective immunity more effectively than dead bacilli prompted extensive investigation
of proteins that tubercle bacilli secrete as potential inducers of protective immune responses
(Bloch and Segal, 1955; Orme, 1988(a)). The fibronectin binding proteins may aid in walling
off the bacteria from the immune system and are involved in the first steps in pathogenesis as
any ligand that binds to fibronectin assists in adhesion, and ultimately invasion of the host by
the pathogen. The antigen 85 complex is one of the best characterized groups of secreted
proteins of M. tuberculosis.
M. tuberculosis is perceived to be an obligate aerobe, even in recent years (Cox, 2003,
Weinstein et al, 2005), despite the fact that there are several publications to the contrary. This
is supported by several observations in animal models and in vitro. The Wayne Model
discussed in detail later clearly indicates that M. tuberculosis can grow under conditions of a
self-generated oxygen gradient. This capability could serve the organism in its interactions with
macrophages. Inhalation of M. tuberculosis results in phagocytosis by alveolar macrophages.
Before macrophages are immunologically activated, M. tuberculosis blocks maturation of
phagosomes preventing the formation of phagolysosomes (Russell, 2001). Surviving bacteria
are believed to enter a period of non-replicating persistence in the phagosome until waning host
immunity leads to reactivation from the latent state and the onset of disease (Wayne and
Sohaskey, 2001). This non-replicating state may reflect anaerobic metabolism.
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1.3. Extrapulmonary tuberculosis
Mycobacterium tuberculosis proliferates in the lung which is oxygen rich relative to deeper
tissue within the host, thus fueling the concept that M. tuberculosis is a strict aerobe.
M. tuberculosis can colonize and cause disease in any organ system of the body. Even though
pulmonary tuberculosis remains the most common form of the disease, extra pulmonary
tuberculosis (EPTB) remains a significant clinical problem (Sharma and Mohan, 2004). The
lungs are indeed a site rich in oxygen. However, in order for oxygen to be used as a final
electron acceptor, the redox conditions need to be electropositive. Even the surface of the skin
has an electronegative redox potential, and the level of electro-negativity increases in deeper
tissues of the body. This therefore impedes the utilization of oxygen as final electron acceptor
(Mclane et al, 1999).
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1.4. Anti-mycobacterial drugs and drug resistance
1.4.1. Treatment and Drug resistant tuberculosis
In the last decade, the prevalence of tuberculosis (TB) has increased 20% worldwide with the
highest burden in the most impoverished communities. If these trends continue, the TB
incidence is expected to increase by 41% in the next twenty years (Outsourcing-Pharma.com,
2005). Fifty years since the introduction of an effective chemotherapy, TB remains a leading
public health problem.
Even in industrialized nations with some of the best healthcare systems in the world, TB
outbreaks transpire. In the early 1990s New York City witnessed an outbreak of drug-resistant
TB and spent $1 billion fighting 4,000 cases (Fogarty International, 2007). In 2007 London was
becoming the TB capital of the world, with double the level of New York’s case load during
that outbreak (All-Party Parliamentry Group, 2007)
Drug-resistant tuberculosis has been reported since the early days of the introduction of
chemotherapy. Most of this was reported from developed countries. In 1992, the Third World
Congress on Tuberculosis concluded that there was little recent information on the global
magnitude of multidrug-resistant tuberculosis (MDR-TB), defined as resistance to at least
isoniazid and rifampicin. MDR-TB is now at critical levels in specific regions of the world.
Areas where MDR-TB occurs with high frequency include Estonia, Latvia, the Oblasts of
Ivanovo and Tomsk in Russia, and the Henan and Zhejiang Provinces in China (Toungoussova,
et al, 2006). The emergence of multi-drug resistant strains has hastened the search for more
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effective treatments.
The importance of rapid detection of drug resistant tuberculosis is constantly in the spotlight.
The answer is sought in the application of molecular assays. Tests of this nature may offer rapid
alternatives to current diagnostic procedures allowing for higher throughput of samples. The
most widespread application of molecular techniques in the study of tuberculosis focuses on the
study of the evolution of resistance mechanisms and through that the development of tests to
detect these.
Isoniazid (INH) is a pro-drug that requires activation by susceptible tubercle bacilli. It was
introduced in the 1950s and soon after, it was observed that clinical isolates manifesting
resistance to this drug, lost its catalase and peroxidase activity. In addition, it is noted that the
activity of INH is restricted to actively “growing bacilli” and is not active against “non-
growing” cells (Siddiqi et al, 2007; Zhang 2004). The association with the katG gene and
resistance to isoniazid was confirmed in the early 1990’s when this gene was cloned and
sequenced (Herrera et al, 2004). A mutation was detected that allowed the bacteria to retain up
to 50% of its catalase activity without activating the drug – and thus a highly effective
resistance mechanism was born. It has also been proposed that isoniazid blocks the production
of mycolic acids, a critical cell wall component in mycobacteria.
One of the foremost causes of treatment failure and fatal clinical outcome in tuberculosis
patients is the resistance to rifampicin (Mitchison and Nunn, 1986). This drug serves to inhibit
transcription by inhibiting the DNA-dependant, RNA polymerase (coded for by the rpoB gene).
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Pyrazinamide (PYZ) is reported to target an enzyme involved in fatty acid synthesis. (Zimhony
et al, 2000) It is also a pro-drug that is converted to its active form, pyrazanoic acid, by the
enzyme pyrazinamidase (Somoskovi, et al, 2001).
1.4.2. The Evolution of Mycobacterium tuberculosis: eukaryotic traits and recent
developments
Mycobacteria belong to the order of gram positive rods known as Actinomycetales. There have
been several studies in recent years using genomic technologies that have revealed some
unexpected characteristics of Mycobacterium tuberculosis. Av-Gay and Everett (2002) revealed
in their review the presence of genes coding for eukaryotic-like kinases that played a role in
cellular signaling pathways. Protein phosphorylation is a mechanism by which extracellular
signals are translated into cellular responses. This process is controlled by highly specific
protein kinases and is directly linked to de-phosphorylation reactions that are controlled by
protein phosphatases.
In prokaryotic cells this system consists of histidine kinase sensors and their associated
receptors (Parkinson, 1993). In eukaryotic cells signaling transduction pathways are maintained
by phosphorylation of serine, threonine or tyrosine. Previously, serine, threonine and tyrosine
phosphate and their respective phosphatases were thought to be exclusive to eukaryotic cells
(Verma and Maurelli, 2003). However, in 1994 Chow and colleagues showed that eukaryotic-
like signal transduction occurs in M. tuberculosis as well as in some other bacteria including
Streptomyces (a related genus), Anabaena and Myxococcus. Av-Gay and Davis (1997) further
12
demonstrated that at least 6 proteins were phosphorylated in vitro confirming that the genes
were not just present but functional as well. Full genome sequencing of strain H37Rv by Cole
and colleagues (1998) showed that there were in fact eleven genes coding for putative
eukaryotic-like protein kinases present. Av-Gay and Everett (2002) proposed an interesting
hypothesis that implied these protein kinases to be involved in various mechanisms of
pathogenesis. These propositions are in the process of being tested.
A further example of the presence of eukaryotic genes is that of genes coding for the
cytochrome P450 enzymes. Azole antifungals are reported to be potent inhibitors of cytochrome
P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes (McLean et
al, 2002). Seven of these CYP450 enzymes were genetically coded for in Bacillus subtilis.
This was the highest number of such enzymes ever observed in bacteria. The H37Rv genome
revealed the presence of 22 such enzymes coded for in M. tuberculosis (Cole, 1998).
Studies into the binary fission process have highlighted the function of the ftsZ gene in septum
formation during cell division (Dziadek, et al, 2002). They also infer a link between the
formation of what they call the “Z-ring” and the formation of clumps due to the modification of
phospholipid synthesis and possible effect on septa formation. This is of significance as it is
well known that clumping is more prominent in the virulent strains of M. tuberculosis when
compared to the avirulent strains (Zhang , et al 1998).
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1.5. Latent tuberculosis – the ability to persist
“Some PPD-positive individuals can develop active disease after an asymptomatic interlude”
(Gedde Dahl, 1952). This statement made so many decades ago indicates the ability of the
microorganism to undergo a period of dormancy and subsequent endogenous reactivation. In a
study that combined epidemiological evidence with molecular fingerprinting data, reactivation
of tuberculosis in an individual after 33 years of latent infection was convincingly demonstrated
(Lillebaek, 2002). However, up till now the concept of clinical latency is still not fully
understood. It is possible that this results from bacteria achieving a modified metabolic, non-
replicative state. It is further possible that constant bacterial numbers result from a dynamic
equilibrium between bacterial replication and elimination by the host (Parish, et al, 1998).
The idea that the bacteria can enter a dormant state during human infection was strengthened
by studies where diseased tissues staining positive for acid-fast bacteria did not yield bacteria on
culture or the bacteria grew very slowly. Dormant tubercle bacilli have been reported to remain
inactive in the host tissue without any sign of infection, and most cases of tuberculosis are said
to be due to the reactivation of dormant Mycobacterium tuberculosis bacilli rather than to recent
infection (Smith & Moss, 1994). Because of prolonged periods of asymptomatic latent
infection, it becomes critical to distinguish between replicating and non-replicating bacterial
cells in specimens. Hellyer et al (1996) demonstrated that mycobacterial DNA was still detected
in clinical specimens even a year after treatment.
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In murine models, mycobacterial DNA was detectable during active disease when cells were
culturable and also during the latent phase when cells were not detected under standard culture
conditions. Different models of latency were established to study the pathogenesis pathways of
M. tuberculosis. One such model involved mice that were infected by aerosol with a low dose
of M. tuberculosis (5 to 10 colony forming units), and within 3 months the bacterial load
stabilized at 3 to 4 log10. This is known as the low dose model (Orme, 1998(b)).
In this model the clinically inactive phase of the infection was maintained for 15 to 18 months,
after which time the infection began to reactivate and the mice succumbed to the disease. This
low-dose model is believed to resemble natural latency in the sense that it relies solely on the
host immune response for control of the infection, but it differs from human infection by the
high bacillary burden in the latent phase which is not found in human latent M. tuberculosis
infection. (Orme, 1998(b)) Using a modified low-dose model of murine latent tuberculosis, it
was demonstrated by Flynn and colleagues (1998) that reactive nitric intermediates (RNI) play
an important role in preventing reactivation of the infection.
The second animal model of M. tuberculosis latency has been referred to as the Cornell model
and was first described in the late 1950s (McCune and Tompsett, 1957). In the Cornell model,
mice are inoculated intravenously with 1x 106 to 3 x 106 viable bacilli with the H37Rv strain of
M. tuberculosis. The resultant infection is treated for 12 weeks with the anti-mycobacterial
drugs isoniazid (INH) and pyrazinamide (PZA). Treatment commenced within 20 minutes
after infection. It appeared in this model that the anti-mycobacterial treatment was effective as
there was no trace of culturable tubercle bacilli at the time of completion of the antibiotic
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course. In addition it was reported that there is persistence of significant quantities of M.
tuberculosis DNA throughout the various stages of the model and that this may represent dead
bacilli, free DNA or dormant forms (De Wit, et al, 1995).
However 90 days after the anti-mycobacterial treatment ceased, culturable tubercle bacilli were
once again detected. This drug-induced model of latent tuberculosis has the advantage of
achieving very low or undetectable numbers of bacilli and maintaining those low levels for
many weeks, analogous to latent infection in humans. Because this mode of latency is drug
induced, it does not necessarily reflect the natural course of infection in humans. This is
especially notable due the fact that many people, particularly in resource poor countries, may
harbour mycobacteria for months or even years before seeking treatment. Recently there have
been several investigations at the genomic level into expression profiles of M. tuberculosis, in
an attempt to gain a more comprehensive knowledge of survival mechanisms and pathogenesis.
Fenhalls and colleagues (2002) detected transcripts of M. tuberculosis in human lung tissue that
revealed differential gene expression in necrotic lesions. They described necrotic regions as
follows: three distinct regions can be classified, the lymphocyte cut-off, the transition zone and
the necrotic region. The transition zone is characterized by a depletion of oxygen and nutrients,
two critical growth factors. Although they did not detect any gene expression in the necrotic
region, they acknowledge that there could be an upregulation of genes not studied in their
experiment, or even that their methods may not have been sensitive enough to detect low levels
of expression under the restrictive conditions of the core of the necrotic granuloma. The
necrotic granuloma model has been extensively scrutinized and it is widely believed that long
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term survival of the tubercle bacilli is rooted in the ability of cells to survive in the core of such
a structure. Bentrup and Russell (2001) explain how cells can survive using the fatty acids that
are present as a substrate to fuel essential cellular processes. Latent infection is thus ultimately
thought to result from major shifts in gene expression and metabolism, allowing persistence
with minimal replication (Manabe and Bishai, 2000).
In 1933, survival of tubercle bacilli was reported in sealed liquid cultures held at 37OC for as
long as 12 years (Corper and Cohn, 1933). Variations were seen in the pH of these cultures, but
only those between pH 6.1 and 7.6 yielded viable bacilli (Wayne and Sohaskey, 2001).
This was the first report of the microorganisms’ ability to survive long term under challenging
circumstances. One should note that the culture systems were sealed with no replenishing of
nutrients resulting in redox potentials that are specific to anaerobic conditions. This is a
significant observation as it highlights how resilient M. tuberculosis is and it substantiates our
choice of culture model for this study.
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1.6. The H37Rv Genome
In 1998 Cole and colleagues published the complete genome sequence of the laboratory strain
H37Rv. This was a significant milestone in the pursuit of understanding tuberculosis. This
paper was pivotal in the selection of the genes examined in this study. This section (1.6) is a
discussion and summary of key points from this paper. The H37Rv genome comprises of 4.4
million base pairs which constitute approximately 4000 genes. Cole and colleagues offer a
detailed discussion of the different coding regions of the genome with emphasis on lipid
metabolism and a diverse array of potential pathways. The genome also consists of genes that
have a role in anaerobic functions as well as a vast array of enzymes with various functions
which are summarized below.
Approximately 10% of the genome consists of genes named the PE and PPE families. The
names derive from the presence of conserved proline-glutamate (PE) or proline-proline-
glutamate (PPE) residues near the N-terminus of the predicted proteins coded for by these genes
(Glickman and Jacobs, 2001). A large portion of the M. tuberculosis genome is involved with
lipid biosynthesis. One of the most important classes of genes is the homologues of the fatty
acid β-oxidation system of E. coli. The E. coli fatty acid dehydrogenase (FAD) system consists
of the fadA, fadB, fadC, and fadE genes. The M. tuberculosis genome contains in excess of
thirty fadD and more than 30 fadE homologues.
The presence of multiple homologues of β-oxidation machinery suggests that M. tuberculosis
assimilates fatty acids as important carbon sources. According to the authors (Cole, et al,
1998), mycobacteria further contain examples of every known lipid and polyketide biosynthetic
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system, including enzymes usually found in mammals and plants as well as the common
bacterial systems. In total, there are approximately 250 distinct enzymes involved in fatty acid
metabolism in M. tuberculosis compared with only 50 in E. coli.
From the genome sequence it is clear that the tubercle bacillus has the potential to synthesize all
the essential amino acids, vitamins and enzyme co-factors. The sequence data also revealed that
M. tuberculosis, previously known to be a “strict aerobe”, codes for several components
involved in anaerobic electron transport as well as anaerobic pathways of metabolism. This
supported observations made by Wayne in the late 1970’s where he demonstrated the ability of
the H37Rv strain to grow under a self-generated oxygen gradient developing extremely slowly
under anaerobic conditions of growth. Components of several anaerobic phosphorylative
electron transport chains are also present, including genes for nitrate reductase (narGHJI), and
fumarate reductase (frdABCD).
Cole and colleagues report that based on their combined observations, “it can be deduced that
horizontal transfer of genetic material into the free-living ancestor of the M. tuberculosis
complex probably occurred before the tubercle bacillus adopted its specialized intracellular
niche”. Prior to the disclosure of the complete genome sequence of H37Rv, very little was
known about the molecular basis of virulence of M. tuberculosis. This article has singularly
catapulted molecular investigations into pathogenesis of M tuberculosis, and has been used in
amongst other things the design of microarray studies that examine hundreds of genes
simultaneously. Re-annotations of the genome have been reported by the same group of
authors.
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1.7. The Wayne Model
The Wayne model describes the growth of Mycobacterium tuberculosis under different
conditions of oxygen tension. Wayne and Lin (1982) reported that when M. tuberculosis is
grown in a detergent containing medium, and the culture is left undisturbed, equilibrium is
established between the rate of replication, oxygen diffusion and the rate of bacilli settling at the
bottom of the tube. Actively replicating bacilli die rapidly when they are abruptly derived of
oxygen (Wayne & Diaz, 1967; Wayne and Lin, 1982). They have however been shown to shift
into a stage of dormancy when they are allowed to adapt to gradually decreasing oxygen
(Wayne, 1976). This can be linked to the action of the dormancy regulon (Voskuil, 2004).
In his study on “submerged” cultures of M. tuberculosis, Wayne (1976) showed that tubercle
bacilli which have settled through a self-generated oxygen depletion gradient in unagitated
culture tubes undergo an orderly metabolic shift. As they accumulate in the bottom of the tubes
they enter a homogenous physiologic state of dormancy. The shift into first stage, designated
non-replicating persistence (NRP) stage 1, occurs abruptly at a point when the dissolved
oxygen level approached 1%. This micro-aerophilic stage is characterized by a slow rate of
increase in turbidity without a corresponding increase in numbers of CFU or synthesis of DNA.
It was demonstrated by Wayne and colleagues, that abrupt transfer of vigorously aerated
cultures of M. tuberculosis to anaerobic conditions results in rapid death, but gradual depletion
of available oxygen permits expression of increased tolerance to anaerobiosis. Those studies
used a model based on adaptation of un-agitated bacilli as they settle through a self-generated
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oxygen gradient. This is a key concept in understanding the nature of the work presented in this
dissertation, as it demonstrates that M. tuberculosis requires a “period of adaptation” to
changing environmental conditions. The elucidation of the dormancy regulon (Voskuil, 2004)
explains these observations. In this regulon a number of genes are selectively expressed in
response to changes in environmental stimuli.
In contrast to the rapid depletion of oxygen in vigorously rotated cultures, the cultures subjected
to slow magnetic stirring with no detectable disturbance of the surface of the medium had a
much slower rate of equilibration with the air, and the headspace exhibited a much slower rate
of oxygen depletion. When the oxygen content of the headspace air had been reduced by only
28%, an abrupt deflection in the turbidity curves occurs, and the rate of turbidity increase and
headspace oxygen depletion paralleled one another until the oxygen was gone and the
exponential increase in turbidity ceased (Wayne and Hayes, 1996). This means that cells were
multiplying rapidly until approximately 30% of the oxygen was used up. The increase in turbity
(biomass) thereafter was parallel with the oxygen depletion. At this point the turbidity
(biomass) did not increase. This indicates that the number of new cells formed is equal to the
number of existing cells that were dying. This is typical of the stationary phase in the typical
bacterial growth curve.
Unexpectedly, this stage of slow increase in turbidity was not reflected in an increase in CFU.
This means that there was an increase in biomass in the liquid culture but this was not
detectable on aerobically incubated agar plates. This meant that the fraction of cells responsible
for the increased biomass in the liquid media were not able to multiply on agar surfaces.
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Wayne suggests that this period during which turbidity increased slowly without significant
change in CFU counts, provides a model for studying the ability of tubercle bacilli to survive
under conditions that do not support replication. This might be of value since it may resemble
conditions encountered in inflammatory or necrotic tissue (Wayne, 1994). At the point where
oxygen depletion showed a negative effect on replication, production of GDH (glycine
dehydrogenase) began to rise, reaching a peak more than 10-fold higher than baseline and then
declining to about half that level. It was previously postulated that this enzyme provides a
mechanism for regenerating essential NAD as an adaptation to hypoxic conditions (Wayne and
Sohaskey, 2001).
When the dissolved oxygen content of the culture dropped below about 0.06%, the bacilli
shifted down abruptly to a stage, designated NRP stage 2, in which no further increase in
turbidity was seen and the concentration of glycine dehydrogenase declined markedly.
The ability of bacilli in NRP stage 2 to survive anaerobically was shown to be dependent on
having spent sufficient transit time in NRP stage 1. This relates back to the dormancy regulon.
It has been suggested that the ability to shift down into one or both of the two non-replicating
stages, corresponding to micro-aerophilic and anaerobic persistence, is responsible for the
ability of tubercle bacilli to lie dormant in the host for long periods of time, with the capacity to
re-activate and cause disease at a later time. A slow depletion of oxygen appears to permit the
occurrence of adaptations that favour long-term non-replicating persistence of tubercle bacilli
under micro-aerophilic conditions and also enhance the ability of the bacilli to survive under
anaerobic conditions. This versatility could account for long-term latency of tuberculosis in the
mammalian host (Wayne and Sramek, 1994).
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Bacilli also persist in necrotic areas of host tissue which may be acellular and/or avascular and
are thus exposed to a very wide range of physiologic conditions (Wayne, 1994). The model
described here holds promise as a tool to help clarify events at the molecular level that permit
the bacilli to persist under adverse conditions and to resume growth when conditions become
favourable. It can also be used for screening drugs for the ability to kill tubercle bacilli in their
different stages of non-replicating persistence.
In further studies using the settling bacilli culture model, Wayne and Sramek (1979)
demonstrated the presence of antigenic components that were unique to the resting bacilli. In
this study, protein extracts were prepared from aerobically growing cells of M. tuberculosis and
presumed non-replicating cells derived from the sediments of non-agitated cultures. Although
both preparations shared a number of antigens, the extracts of the non-replicating cells further
contained components that were not present in the aerobic extracts. These antigens were then
visualised using immunoaffinity chromatography and immunoelectrophoretic techniques.
These antigens are referred to as the URB (unique to resting bacilli) antigens. This demonstrates
that the bacterial cells react differently due to the external conditions to which they are
subjected. This is critical to understanding the pathogenesis of tuberculosis. Wayne’s Model of
culture was chosen as the basis for the experimental design for the project presented here. The
advantages of the Wayne model are summarised by Dick T (2001) in his correspondence to the
Journal of Antimicrobial Chemotherapy where he states that this model makes the molecular
mechanisms of dormancy, experimentally accessible.
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1.8. Understanding Anaerobiosis
The word “anaerobic” when directly translated means “without air”. This term is often
interpreted as “without oxygen”. There are various terms that define differing states of oxygen
availability. Anoxic refers to the absence of oxygen. Hypoxic refers to the presence of traces of
oxygen insufficient for cells to function normally. Anaerobic generally refers to conditions
where molecular oxygen is absent but it is still present in a bound form through sulphates and
nitrates etc. The concept of varying oxygen tensions is extensively covered in studies on
biofilms (Yu and Bishop, 1998).
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1.9. Redox Potential
Redox chemistry is central to the energy conservation in both photosynthetic processes as well
as cellular respiration. Substances vary in their ability to accept or donate electrons. The ability
of a substance to accept or donate electrons is referred to as its redox potential. This is
designated as the EO value of the substance. A chemical oxidation is defined as loss of electrons
while a reduction refers to a gain of electrons. A hydrogen atom consists of a single proton and
a single electron. When it becomes oxidized, the hydrogen atom becomes a proton. However,
electrons cannot exist in isolation and therefore redox reactions are also called half-reactions.
Hydrogen is the reference standard against which all other redox potentials are measured.
Most molecules can serve as both electron donors and electron acceptors at different times,
depending on what other substances they react with. The association between redox reactions
and the environment in which cells function is reflected in the concept of the electron tower
(Figure 1.1). The electron tower represents a range of redox potentials arranged from the most
negative on the top, to the most positive at the bottom. Generally, extremely electropositive
conditions favour aerobic processes and extremely electronegative conditions favour anaerobic
processes. The reduced redox couple at the top has the greatest potential energy while that at the
bottom has the least. The redox couple at the bottom however has the greatest tendency to
accept electrons while the opposite holds true for the redox couple at the top. The effect of
redox potential on bacterial growth is complicated and is summarized in the following
paragraph.
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Figure 1.1: Electron Transport Redox Potential Tower (Modified from Brock and Madigan,
Biology of Microorganisms, 6th Ed, pg 97)
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1.10. ATP
The transfer of electrons between different chemical substances results in the formation of ATP
(adenosine triphosphate). ATP is required to drive all major processes in the cell. Many
different chemical processes take place at the cellular level e.g. proteins are formed, metabolites
are released etc, all of which carry a relative charge. The combination of these different
substances results in a net charge that influences the direction of redox reactions. Bacteria have
the ability to adjust and counteract extremes in the environment that would adversely affect its
survival. One such redox mediator is ferredoxin. It is proposed that the expression patterns of
the ferredoxin gene differ in M. tuberculosis cells in different stages of metabolism.
Anaerobic conditions are favoured in environments that tend to be electro-negative. It has long
been recognized that the anaerobic culture of bacteria has a high reducing character. Many
obligate anaerobes will only grow in pre-reduced media. Others will grow in liquid culture with
shorter lag periods if a compact inoculum is used and the medium is not disturbed until growth
is well established. This is clearly demonstrated for Mycobacterium tuberculosis in the case of
the Wayne Model. Facultative growth in bacteria implies that bacteria can grow under both
reduced and oxidized conditions. Phenotypically, facultative bacterial growth in liquid culture is
characterized by floccules that are present throughout the column of broth in a culture vial. This
means that discrete levels of conditions exist within the tube that can create this situation of
supporting aerobic and anaerobic growth simultaneously.
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1.11. The Cell Membrane and Metabolism
1.11.1. Introduction
Free-living bacteria are usually flexible in the way in which they use energy and nutrient
sources. Most species possess a range of electron transport chain components, which can be
expressed according to environmental changes. Adaptable bacteria that can exploit various
sources of
metabolic energy are able to assemble a diverse array of respiratory chains in response to the
availability of electron acceptors (Rothery, et al, 2002). The electron transport chain is located
in the cell membrane.
Bacterial electron transport chains are very similar in nature to those of mitochondria and
photosynthetic systems. The electron transport chain consists of membrane associated electron
carriers. They serve to accept electrons from electron donors and pass them on to electron
acceptors while conserving some of the energy that is released in the process. There are several
types of redox enzymes and proteins involved in electron transport (Brock and Madigan, 1996).
1.11.2. Electron Transport Mediators
The basic description of electron transport components given here has been adapted from Brock
and Madigan (1996). NADH dehydrogenases are proteins that are bound to the inside surface of
the cell membrane. They accept electrons from NADH and pass two high energy electrons to
flavin mononucleotide (FMN) which is a flavoprotein. Flavoproteins contain a derivative of
riboflavin. They are capable of accepting hydrogen atoms and donating electrons.
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Iron sulphur proteins can vary in their iron content, resulting in varying redox potentials. A
common iron sulphur protein is ferredoxin.
Cytochromes are proteins with iron containing porphyrin rings attached to them. They undergo
reduction and oxidation through gain or loss of a single electron respectively.
Quinones are lipid soluble substances involved in electron transport. Like flavoproteins, they
have the ability to accept hydrogen atoms and donate electrons.
Hydrogen atoms are passed from NADH to FMN, which is typically the first acceptor in the
chain. The electron acceptors in the electron transport chain include FMN, ubiquinone (CoQ),
and the closely related cytochromes. Cytochrome molecules accept only an electron from
hydrogen, resulting in the formation of the positively charged protons. ATP Synthase
translocates these protons back into the cell and ATP is formed in the process. Simultaneously,
the electrons reunite with protons to form hydrogen atoms, and the chemical union of the
hydrogen and oxygen produces water.
Oxygen is the final hydrogen acceptor in the electron transport system in aerobic systems.
When no oxygen is available to accept the hydrogen atoms, the last cytochrome in the chain is
stuck with its electrons. When that occurs, each acceptor molecule in the chain remains stuck
with electrons, and the entire system is halted all the way back to NADH. As a result, no further
ATPs are produced through this electron transport system. Most cells of complex organisms
cannot live long without oxygen because the amount of energy they produce in its absence is
insufficient to sustain life processes. Bacteria however, have existed from before the earth’s
atmosphere was able to sustain other life forms. Anaerobiosis would therefore have to be one of
the earliest survival strategies amongst the prokaryotic kingdom.
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1.12. Genes studied
As the biochemical systems involved in aerobic and anaerobic ATP production are complex and
involve many different substances, the scope of the work presented here does not allow
studying all of these. Therefore a choice needed to be made regarding the genes and their
products that would be studied.
1.12.1. Ferredoxin fdxA
The fdxA gene codes for a ferredoxin product. Ferredoxins function exclusively as electron
carriers and do not have classical enzyme functions. They have the ability to absorb and release
negatively charged, sub-atomic particles but they do not act as biological catalysts. The term
“ferredoxin” was first used by D.C.Wharton of the DuPont Company while describing the "iron
protein" obtained from Clostridium pasteurianum (Mortenson, et al, 1962). Ferredoxins
comprise of iron-sulphur proteins that contain several iron and sulphur atoms involved in
electron transfer. Ferredoxin has been reported to function as an electron-mediating catalyst for
the biological production or utilization of hydrogen by bacteria (Mortensen, et al, 1962;
Mortensen, et al, 1963; Valentine et al, 1962, Valentine and Wolfe, 1963).
Early research on bacterial ferredoxin has helped to clarify the concept of low-potential electron
transport. In this process, electrons from an electron donor are passed to oxidized ferredoxin
with the aid of a specific dehydrogenase which converts oxidized ferredoxin to reduced
ferredoxin. In ferredoxin assays performed by the Valentine group, this conversion was
observed with a corresponding colour change from dark brown to colourless. Colourless
ferredoxin donates its electron to the next molecule in the electron transport chain (ETC). In
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this manner, electrons flow from the electron donor to ferredoxin and then to the electron
acceptor. Many hydrogen-producing bacteria oxidize ferredoxin by the hydrogenase reaction
and evolve large quantities of hydrogen gas (Valentine, et al 1963, Mortensen et al, 1962,
Valentine, 1964).
Ferredoxins in M. tuberculosis H37Rv are involved in several reaction types both as a product
and as a reactant. The following reactions are examples of some of the reported activity of
ferredoxin in H37Rv (Biocyc A & B, 2008).
 Glutamate degradation VII (to butyrate) :
oxidized ferredoxin + coenzyme A + pyruvate = ferredoxin + CO2 + acetyl-CoA
 Glycolysis III :
oxidized ferredoxin + coenzyme A + pyruvate = ferredoxin + CO2 + acetyl-CoA
 Pyruvate fermentation to acetate :
oxidized ferredoxin + coenzyme A + pyruvate = ferredoxin + CO2 + acetyl-CoA
 Sulphate assimilation III :
H2O + oxidized ferredoxin + H2S = 3 ferredoxin + SO3
-2
 It may also be involved in reactions as a reactant.
 Glutamate degradation VII (to butyrate) :
 Ferredoxin + 2 H+ = H2 + oxidized ferredoxin
 Reductive acetyl coenzyme A pathway :
5,10-methylene-THF + ferredoxin = 5-methyl-THF + oxidized ferredoxin
 Further to the above ferredoxin may be involved in reactions without pathways.
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 oxidized ferredoxin + ammonia = 3 ferredoxin + NO2
-
 2 oxidized ferredoxin + 2 L-glutamate = 2 ferredoxin + α-ketoglutarate + L-    
glutamine
It has been reported that metronidazole is active against dormant cells of M. tuberculosis.
Metronidazole is activated via the transfer of a single electron from ferredoxin to the nitro group
of the drug, resulting in the formation of a free radical (Quon, et al, 1992). Therefore,
metronidazole has targeted action against anaeroboes. It has no activity against actively dividing
M. tuberculosis cells (Wayne and Sramek, 1994), suggesting the dormant state to be equivalent
with anaerobic metabolism.
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1.12.2. Naphthoate Synthase menB
This enzyme, coded for by menB, plays a key role in the production the respiratory quinones
of bacteria. Bacterial respiratory quinones can be divided into two groups. Firstly
benzoquinones, which are also known as ubiquinones (UQ) and secondly, the group contains
the naphthoquinones which include menaquinone (vitamin K2; MK or MK-n) and demethyl-
menaquinone (DMK or DMK-n). Animal cells synthesize only UQ, while MK is obtained
from the diet (Soballe and Poole, 1999). In prokaryotes, MK plays a role in the anaerobic
biosynthesis of pyrimidines, in addition to its role in electron transport (Gibson & Cox, 1973).
Naphthoate synthase has been reported byTruligo and colleagues (2003) as a potential drug
target. This key enzyme is involved in the pathway leading to the formation of the membrane
soluble menaquinone (vitamin K). The potential use as a drug target is borne from the fact that
humans do not have a vitamin K pathway. They obtain their vitamin K from the diet and
through a mutualistic relation with intestinal flora. A drug that would inhibit the action of this
enzyme would therefore potentially inhibit the electron transport process. Menaquinone is the
sole quinone in mycobacteria making its production pathway extremely attractive as a drug
target.
Some of the earliest work on menaquinone was conducted as nutritional studies in animals. The
discovery of vitamin K biosynthesis in bacteria came from detailed studies of the nutrition of
chickens. In the early 1930’s McFarlane and colleagues (McFarlane et al, 1931) investigated the
fat-soluble vitamin requirements in chicks. The basic foods studied were either fish (white non-
oily fish) or meat (from which the fat was partially extracted). If the fat was extracted from
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either food source, the animals demonstrated poor growth and, if injured, bled to death. The
bleeding condition was most pronounced when ether extracted fish meal (rather than meat) was
used. Almquist and Stokstad in 1935 reported further experiments with fish meal which had
been moistened and allowed to putrefy, with similar findings to Halbrook’s work.
The water-moistened fish was examined by Halbrook in 1935, who found that it prevented
hemorrhagic symptoms in chicks. Dried water extracted nutrients had the same effect. However,
if this powder was further treated with alcohol hemorrhagic symptoms did occur. Halbrook
concluded that the protective action of water extracted fish meal "can only be explained by
bacterial action, especially since mere moistening of the fish meal had a similar effect, whereas
water extraction followed by moistening with ethyl alcohol to prevent bacterial action failed to
prevent the symptoms from occurring." This work on chicks led to the discovery of vitamin K
synthesis in bacteria (Bentley and Meganathan, 1982).
Most of the naphthoquinones found in nature are produced by plants and fungi, and the majority
of these are derived by "'polyketide" pathways (Bentley, 1975). Some bacterial
naphthoquinones are also produced in this way, e.g. a Streptomyces species (McGovern and
Bentley, 1975). While research on Vitamin K in animals was being pursued, Twort and Ingram
in their early work on the cultivation on Mycobacterium paratuberculosis (also known as
Johne’s Bacillus), recognized clearly that not all bacteria and not all strains of the same bacterial
species were sources of “Essential Substance”, now known as vitamin K (Twort and Ingram,
1912 and 1913). Production of this growth factor by M. phlei to stimulate the growth of M.
paratuberculosis was found to be dependent on culture media components. For example,
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glycerol-containing media were good substrates for Essential Substance production. Since each
assay that requires growth of M. paratuberculosis takes about 2 months of incubation, progress
was slow (Bentley and Meganathan, 1982).
These workers aimed at producing a vaccine for Johne's disease, a chronic, specific enteritis
affecting cattle. They postulated that the acid fast bacillus (Johne's bacillus) present in the
intestinal mucous membrane and mesenteric glands of infected animals was the causative agent.
All attempts to cultivate the organism on ordinary, artificial laboratory media had failed. They
considered that these failures must be due, either to some substance in the medium acting as an
inhibitor, or to the absence of a substance essential for its vitality and growth (Bentley and
Meganathan, 1982). Since related bacilli grew in ordinary laboratory media, the inhibitor option
seemed highly improbable. They therefore concluded that the failure to grow the bacillus must
be due to the absence of some necessary nutrient. When dead human tubercle bacilli were
incorporated into an egg medium, Johne's bacillus was grown in culture for the first time. This
result was announced by Twort in a preliminary fashion in 1911 (Bentley and Meganathan,
1982).
Extraction of Mycobacterium phlei cells with ethanol yielded a yellowish mass which supported
growth. On further extraction with chloroform, the best stimulation was obtained with the
material insoluble in chloroform. As Hanks has noted, this work provides the first discovery of
a biological growth factor, a vitamin, for a microorganism (Hanks, 1966). The following
pathway illustrates the formation of menaquinone and the role of the enzyme coded for by
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menB in M. tuberculosis H37Rv. This pathway (Figure 1.2) was obtained online from the
Biocyc Database (Biocyc C, 2008).
Figure 1.2: Pathway for the formation of menaquinone in M. tuberculosis
H37Rv
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1.12.3. Cytochrome B reductase subunit qcrB
As the name indicates, cytochromes are cellular pigments that absorb light at specific
wavelengths via their heme cofactor. Since 1997, the application of spectroscopic techniques
has resulted in the accumulation of a large amount of data on the biogenesis of cytochromes and
cytochrome complexes (Thoney-Meyer, 1997).
Cytochromes are electron transfer proteins that carry heme as a prosthetic group. Their redox
function is intimately related to the valence change of heme iron (Thoney-Meyer, 1997
Yamanaka, 1992). Most bacterial cytochromes function either in photosynthetic electron
transport or in aerobic and anaerobic respiration, whereby ATP formation is coupled to the
oxidation of reduced substrates such as organic substances, hydrogen, reduced sulphur, or
metals. Since respiration takes place in the cytoplasmic membrane, cytochromes are often
localized in this compartment. In addition, they are found in the periplasmic space, where their
electron transfer function is connected with that of membrane-bound cytochromes. In many
cases, cytochromes are assembled in multi-subunit enzyme complexes that may contain
additional non-heme cofactors. However, they can also occur solitarily, e.g. when they function
as mobile, periplasmic electron shuttles between other membrane-bound respiratory complexes
and their reaction partners.
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The cytochrome bc1 complex (quinol:cytochrome c oxidoreductase) is an integral membrane
protein complex that functions as part of an electron transfer chain by passing electrons from
quinol in the membrane to a c-type cytochrome. Coupled to electron transfer is the transport of
protons across the membrane, and consequently, the enzyme contributes to the proton motive
force. The complex has been isolated from mitochondria and several bacteria (Yu and Brun,
1998).
Cytochrome b is an integral membrane protein with nine predicted hydrophobic α-helices, of 
which eight appear to span the membrane bilayer, with two heme molecules bound non-
covalently to conserved histidines in transmembrane helices II and IV. The last three
transmembrane helices represent a protein domain that in chloroplast or cyanobacterial bc1-like
complexes occurs as a separate subunit IV. The genes encoding bacterial bc1 complexes have
been cloned and sequenced from a variety of species (Brand et al, 1992; Davidson and Daldal,
1987, Gabellini and Sebald, 1986; Kallas, et al, 1998). They are called fbc, pet, or qcr genes.
The bacterial complex III genes are organized in one operon or, in the case of cyanobacteria,
two operons, and they are present in different combinations. Various respiratory complexes
consist of cytoplasmically active enzymes that are anchored to the membrane by one or two
subunits which often are b-type cytochromes. These subunits connect the cytoplasmic redox
reactions with electron transport to or from the quinone and quinol pool in the membrane.
38
1.12.4. Fumarate Reductase frdA and Succinate Dehydrogenase
These components are discussed together, as they have similar structure and related functions in
terms of the TCA (tricarboxylic cycle). Succinate dehydrogenase and fumarate reductase are
enzyme complexes similar both in composition and in subunit structure. In vivo however, they
normally catalyze their enzymatic reactions in opposite directions (Ackrell et al, 1992).
Succinate dehydrogenase plays an important role in cellular metabolism and directly connects
the Krebs cycle with the aerobic respiratory chain (Hagerhall, 1997). Fumarate reductase
catalyzes the final step in anaerobic respiration with fumarate as a terminal electron acceptor
(Kroger A, 1978). These enzyme complexes are thus examples of the high evolutionary
adaptation of organisms to specialized environments (Hagerhall, 1997).
There has been plenty of research on these components conducted in E. coli. Singh and Gosh
(2006) reported that the biochemical reactions of the E. coli TCA cycle and that of M.
tuberculosis were theoretically identical. It stands to reason then that findings in E. coli may
shed some light on the metabolic mechanisms of M. tuberculosis. This is important to note as
this central metabolic process is far easier to study in E. coli than the slow growing M.
tuberculosis.
At the beginning of life the atmosphere was not able to support aerobic life forms. It is only due
to the oxygen generated by the ancient cyanobacteria that the atmosphere eventually evolved to
be able to support what we know today as higher life forms. Microorganisms that existed at the
time were almost exclusively anaerobic (Margulis and Schwartz, 1998). After the accumulation
of oxygen from this photosynthetic bacterial metabolism (Summons et al., 1999; Brocks et al.,
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1999), organisms began to use the citric acid cycle in the oxidative direction. Srinivasan and
Morowitz (2006) show through deductive reasoning that the reductive TCA therefore did
precede the classical oxidative TCA. Smith and Morowitz (2004) discuss the evolutionary path
of metabolism with the reductive TCA as a central process from which other complex
biological reactions could have developed.
The TCA cycle is also known as the Krebs cycle. This cycle is the foundation of most
intermediary metabolism. It also has been identified as having a central role in microbial
survival in hostile and difficult environments that are progressively nutrient-starved and
oxygen-depleted (Gomez and McKinney, 2004; Voskuil et al., 2004; Wayne and Sohaskey,
2001). The model that our study is based on is a reflection of such a situation, as the liquid
media is sealed and left undisturbed over an extended period of incubation. This results in
gradual starvation and oxygen depletion.
An organism that utilizes multiple energy sources must be able to maintain the balance of
oxidative and reductive reactions in the metabolic scheme. Reducing agents involved in ATP
formation  are generated via aerobic conditions through  glycolysis, the Krebs cycle, and β-
oxidation pathways. These reducing agents could be re-oxidized efficiently through the
electron-transport chain, terminating with electron transfer to oxygen. However, under oxygen-
limiting micro-aerophilic and anaerobic conditions, severe restrictions may be imposed on the
redox potential, leading to redox imbalance that results in accumulation of the reducing
equivalents to toxic levels (Srinivasan and Morowitz, 2006). Because tuberculous lesions are
enriched in CO2 (Haapanen, et al,1959), the reductive TCA cycle, with its ability to obtain
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carbon solely from CO2, may allow these reducing equivalents to be used efficiently in the
anabolic mode. Since M. tuberculosis has both the key enzymes for the reverse TCA (rTCA)
cycle, a fully functional cycle in the reverse direction may be able to obtain carbon in the
relatively reductive environment, maintaining replication at a low level that facilitates
persistence anaerobically. It has been already reported that this may well be a common
principle in survival strategies among bacteria that cause persistent infections like Salmonella
and Helicobacter (Monack, et al, 2004; Srinivasan and Morowitz 2006).
In their review on carbon metabolism in intracellular bacteria Munoz-Elias and McKinney
(2006) use M. tuberculosis to explain the role of the TCA in survival and persistence, with
particular emphasis on the survival in macrophages. They also report an evolutionary trend
with a limited role of the TCA in bacteria and a more extensive use of this process in eukaryotic
cells. They give a detailed explanation of the role of the different enzymes in the cycle as well
as the unique features of the TCA in M. tuberculosis. The ability of a bacterial species to use
the processes of the TCA in both directions is significant in their ability to persist. In summary,
the oxidative TCA generates intermediates that are used in other metabolic pathways. As an
example, the α-ketoglutarate intermediate is required for the formation of the membrane soluble 
menaquinone, (see previous section on Naphthoate Synthase). Further to the above, hydrogen
and hydrogenated reducing intermediates are formed and these intermediates drive the electron
mediated formation of ATP. The reverse TCA produces storage fuels that can be used to form
ATP under challenge situations.
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Srinivasan and Morowitz have illustrated the processes in both directions in their paper on
ancient genes in persistent microbial pathogens. The reverse reaction (fumarate to succinate)
occurs in the reverse or reductive TCA and the reaction is catalyzed by fumarate reductase.
Carbon dioxide is taken into the pathway and recycled to form storage fuel intermediates
(Srinivasan and Morowitz, 2006). Anishetty, et al (2005) used advanced bioinformatics and
theoretical modelling to investigate metabolic pathways of M. tuberculosis. They list fumarate
reductase and succinate dehydrogenase as potential drug targets in M. tuberculosis. Fumarate
reductase is particularly earmarked because of its role in anaerobic electron transport processes.
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1.12.5. The Bacterial Ribosome: rrs gene
The number of 16S RNA gene copies per genome equivalent was shown to remain stable
throughout different phases of M. tuberculosis growth in vitro (Desjardin, et al, 2001).
Therefore, the number of copies of this gene per volume of culture medium or clinical specimen
can be extrapolated into the concentration of bacterial cells. Shi, et al (2003) showed that 16S
RNA gene copies showed a linear correlation with the number of colony forming units. The
relationship between the increase in CFU and corresponding 16S transcripts was defined as a
linear relationship defined by the formula : y = 10457x + 3.1093. The correlation co-efficient
for this comparison (R2) was reported as 0.9539.
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1.13. Current Investigations, Techniques and Technologies
To the modern microbiologist a host of techniques are available to conduct studies at both the
genomic and proteomic level. This allowed for the detection and analysis of mechanisms of
resistance, the development of genotyping systems as well as the analysis of pathways of
pathogenesis. Proteomic studies enable scientists to examine functional gene products that play
a role in survival and pathogenesis of the tubercle bacilli. An early example of this is the study
of Wayne and Sramek (1979) that identified what they termed the URB antigen, which was
identified in cells cultured in broth incubated without shaking.
More recent proteomic investigations, like the work of Stark and colleagues (2004) show the
differences in protein profiles of cells grown under different conditions. They show distinct
differences between cells grown under aerobic and anaerobic conditions. Voskuil and
colleagues (2004) described the expression profile of the dormancy regulon using microarray
technology. The regulon consists of 48 genes that are strongly induced over a period of 20 days.
They concluded that this dormancy regulon facilitates a long transition into the anaerobic state.
The dormancy genes appear to encode functions previously described for the Wayne model as
well as functions that may be useful during extended periods of dormancy. In addition to the
hypoxia response, they also demonstrated that the dormancy regulon is induced by nitric oxide
in the early adaptation phase to non-replicating persistence.
Gene expression studies are important in the analysis of cellular processes. Real-time reverse
transcription PCR is a recognized technique for quantifying mRNA in biological samples.
Benefits of this procedure over conventional methods for measuring RNA include its
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sensitivity, large dynamic range, as well as the potential for high throughout and accurate
quantification (Hugget, et al, 2005). While a normal PCR reaction provides information on
whether a gene is present or not, it cannot be used to determine whether this was due to
presence of intact cells, DNA from dead cells or free DNA. On the other hand, the detection of
gene expression indicates the presence of viable cells. Gene expression analysis is a complex
application that can be executed by detecting the mRNA transcript directly or by a 2-step
process that involves extraction of RNA converting it to complementary DNA and then






S e c t i o n 2 : M e t h o d s
2. Methods
2.1. Objective
Mycobacterium tuberculosis is still widely accepted as a strict aerobe, despite the mounting
evidence to dispute that assertion. Our objective is to determine if the infectious organisms in
vivo are indeed in an anaerobic state of metabolism, and to determine what electron transport
components add to its ability to persist under such challenge conditions.
2.2. Introduction
This study is composed of two main experiments. Firstly, we compared the number of M.
tuberculosis organisms in clinical specimens that grew on solid media with those that grew in
liquid media. Secondly, we studied the role of selected genes involved in metabolism during
growth of M. tuberculosis under oxygen limiting conditions. In addition, we attempted to detect
the expression of these genes directly in sputum. Figure. 2.1 summarizes these two
experiments.
This section describes the methodology concisely, and detailed work instruction and protocols
are available in Appendix A as ondicated below.
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Figure 2.1 Schematic Overview of Methodology
Serial Dilution
Inoculation of liquid media
and agar plates
Incubation at 37oC

















2.3. Bacterial Strain and Culture
The laboratory strain M. tuberculosis H37Rv (ATCC 27294) was used for the in vitro gene
expression studies. This strain’s genome sequence has been annotated and compared with
functional genome analysis of other bacterial species. It is the reference strain used in most
experimental studies.
Middlebrook 7H9 supplemented with commercially available OADC (oleic acid, albumen-
dextrose, catalase; Difco) according to the manufacturer’s instructions and made selective by
means of antibiotics. This was used in all experiments. Middlebrook 7H11 agar was prepared
with similar antibiotics and supplements for assessment of sputum specimens (Appendix A
Section 1).
2.4. Quantitative Sputum Cultures
2.4.1. Sputum Collection and Processing
Sputum specimens were collected from consenting patients enrolled in a clinical trial
comparing 2 drug regimens for treatment of pulmonary tuberculosis. This trial was performed
by the Clinical Trial Unit of the Medical Research Council, ethics approval no. T183. None of
the patients were previously treated for tuberculosis. Five patients with positive Auramine
stained smears were used for this experiment.
2.4.2. Serial Dilution Preparation
Specimens were homogenized by shaking with glass beads for 30 minutes. A commercially
available ditheiotritol solution (Sputasol®, Oxoid) was added at a 1:1 ratio. This mixture was
vortexed for 20 seconds following which 12 ten-fold serial dilutions were made in
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Middlebrook 7H9 broth. From each dilution 200 µL aliquots were plated out on Middlebrook
7H11 agar. Middlebrook 7H9 broth cultures (10 mL in 15 mL tubes with a diameter of 10
mm, Fig 3.3) were also inoculated with 200 µL of each dilution. Agar and broth cultures were
prepared in triplicate.
2.4.3. Incubation of inoculated media
Plates were sealed in gas permeable plastic bags while the tubes were tightly sealed with
screw-caps. Both plates and tubes were incubated at 37oC for 10 weeks. Plates were inspected
for growth after 3, 6, 8 and 10 weeks of incubation. The liquid cultures were examined for
growth at the same time points as the plates without disturbing the liquid.
2.4.4. Determination of Organism Density
The organism density in the sputum was determined according to Fisher and Yates (1963)
using the following formula
log  = x log a – k
Where:
x = mean fertile level (the total number of tubes or plates with growth divided by the number
of replicates at each dilution level)
a = dilution factor = 10
k = constant derived from the published table
This method was used for both types of growth media.
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2.4.5. Confirmation of the Presence of M. tuberculosis and Absence of Contaminants
To determine whether the growth observed was indeed M. tuberculosis a PCR for the
detection of the IS6110 insertion sequence (Eisenach et al. 1990) was used. Colonies from the
Middlebrook 7H11 agar plates from each dilution showing growth were suspended in sterile
phosphate buffered saline (PBS), pH 6.8 with 0.05% Tween 80 and glass beads. The
suspensions were vortexed and DNA was extracted by heating 1 ml aliquots at 95OC for 30
minutes. Aliquots of each broth culture showing growth were prepared in the same manner.
The agar plates were inspected for the presence of colonies with morphology not in keeping
with M. tuberculosis while 200µL aliquots from each tube showing growth were inoculated
into blood agar and incubated at 37oC for 24 hours.
2.4.6. Ethics approval
Ethics approval was obtained from the Biomedical Research Ethics Committee of the
University of KwaZulu-Natal (H125/06).
2.5. Gene Expression Studies
2.5.1. Inoculum Preparation
A log phase culture was established by inoculating 20mL of a culture of M. tuberculosis H37Rv
into 180ml fresh Middlebrook 7H9 broth. This was incubated in a regular incubator for 10 days
at 37oC on a horizontally rotating plate. Of this log-phase culture, 2mL was added to each of
three series of 15 tubes containing 8mL Middlebrook 7H9 broth. The tubes were placed in a
regular incubator at 37oC and left undisturbed till the time-point of RNA extraction.
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RNA was extracted from the growth in 3 tubes at day 0 and after 3, 6, 8, 9, 10, 11, 12, 13, 14
and 15 weeks of incubation.
2.5.2. Primer and Probe Design
Primers and probes were designed for use with the ABI PRISM 7000SDS. For each selected
gene the sequence was downloaded from three different databases (Research Tools, 2006;
Tuberculist, 2006; Sanger, 2006) and compared in GeneDoc software (GeneDoc, 2006,
Appendix A Section 2). Since the entire gene sequence was identical from each database, the
entire gene sequence was uploaded in primer express software version 1.1 to generate primer-
probe combinations. A section consisting of 200 bases was selected that included the region
containing the highest ranking primer-probe combination. This was uploaded into Assay File
Builder Software (Applied Biosystems Support, 2006) and sent to Applied Biosystems for
optimal custom assay design. The sequences are shown in Table 1. Products of the genes
investigated are represented in Figure 2.2.
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Table 1: Primer and Probe Sequences
Sequences for men B
Forward Primer CCGCCACGTCGACGAT
Reverse Primer GCACTTCAGGGCGGTTGA
Taqman MGB Probe ACGCCACCCGCACCGT
Sequences for fdx A
Forward Primer CGACGAGTGCGTGGATTGT
Reverse Primer GGTAGATCGCCTTCCCAGTAGAT
Taqman MGB Probe CCGGTTTGCACGCACC
Sequences for qcr B
Forward Primer CGTTGGTGTGGTTCCAGAAG
Reverse Primer CGCCGACGACGTTGTG
Taqman MGB Probe CACACCCAGTTCCC
Sequences for frd A
Forward Primer CCCAACACAACATCGTGGTTATC
Reverse Primer GGAAACGATCGCCACATCCA








Taqman MGB Probe CCGGCTACCCGTCGTC
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2.5.3. RNA extraction, conversion to cDNA and quantitation of products
A combination of physical and chemical methods was used to extract the RNA from the
mycobacterial cells. The RNA was then converted to cDNA for further evaluation. Broth
cultures were centrifuged (20 min. 4500 x g) and after removal of the supernatant, the deposit
was resuspended in 2 mL Trizol Reagent ® (Invitrogen, USA). The suspension was then
transferred into an Eppendorf tube containing 300 µg silica beads with a diameter of 150-212
m (Sigma, USA) and vortexed to disrupt the cells.
The efficiency of cell disruption was verified microscopically after Ziehl Neelsen staining (Fig.
3.4).
Figure 2.3a Ziehl Neelsen stain of vortexed H37Rv cells. And Figure 2.3b Ziehl Neelsen
Stain of H37Rv vortexed with glass beads and Trizol®.
A detailed protocol for RNA extraction is available in Appendix A Section 3.
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The extracted RNA was quantified by means of the Nanodrop-1000 (NanoDrop Technologies,
Wilmingon USA). High-Capacity-cDNA Archive Kit (Applied Biosystems, Worrington,
Cheshire, UK) was used to convert 2µg of RNA from each RNA extract into cDNA. PCR was
conducted in 100µL reaction volumes and detailed steps are given in Appendix A Section 4.
Quantities containing 2µg of RNA used for reverse transcription are given in Table 2.
Table 2: Quantities of RNA used to ensure 2ug conversion per reaction.
The efficiency of the cDNA conversion was evaluated by comparing the cDNA
quantities.Figure 2.4 shows that the quantities were similar after the conversion. The quantity

































DO 90.16 22.18 27.82 82.60 24.21 25.79 66.60 30.03 19.97
Wk3 102.69 19.48 30.52 88.62 22.57 27.43 121.64 16.44 33.56
Wk6 179.24 11.16 38.84 154.22 12.97 37.03 189.98 10.53 39.47
Wk8 153.66 13.02 36.98 182.54 10.96 39.04 155.55 12.86 37.14
Wk9 157.30 12.71 37.29 136.21 14.68 35.32 148.32 13.48 36.52
Wk10 397.78 5.03 44.97 485.62 4.12 45.88 422.27 4.74 45.26
Wk11 207.14 9.66 40.34 175.34 11.41 38.59 263.36 7.59 42.41
Wk12 161.96 12.35 37.65 144.64 13.83 36.17 178.30 11.22 38.78
Wk13 148.63 13.46 36.54 165.65 12.07 37.93 188.89 10.59 39.41
Wk14 186.16 10.74 39.26 199.30 10.04 39.96 241.10 8.30 41.70
Wk15 164.33 12.17 37.83 144.60 13.83 36.17 198.99 10.05 39.95
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Figure 2.4 Screen capture of typical cDNA output data from Nanodrop1000 showing a
similar quantity range between the different time points
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2.5.4. Quantitative Real Time PCR
Genomic DNA was used to generate standard curves (Talaat et al, 2002). Quantities for the
standard curve and a DNA extraction protocol are given in Appendix A, Sections 5 and 6
respectively. PCR reactions were performed in 25 l volumes in a 96 well Optical Reaction
Plate (Applied Biosystems, Worrington, Cheshire, UK) by adding 1.25 l Primer-Probe-Assay
reagent (Applied Biosystems, Worrington, Cheshire, UK) and 12.5 l Universal Mastermix
(Applied Biosystems, Worrington, Cheshire, UK) to 11.25 l of a 1:5 cDNA solution. Each
reaction was conducted in triplicate. Amplicon quantities were determined using a standard
curve generated with genomic DNA of M. tuberculosis H37Rv. The real-time PCR reactions
were conducted using an ABI-7000-SDS. Separate PCRs were performed with each primer-
probe assay reagent shown in table 3.1. Gene expression levels were normalized against the 16S
ribosomal RNA quantities at each time point. A detailed protocol with instruction on
interpretation of graphical data from the ABI 7000 SDS is available in Appendix A section 7.
2.6. Sputum processing for gene expression studies
Specimens were digested and decontaminated by means of the standard NALC-NaOH method
(Desjardin et al). The methods for isolation of RNA and for gene expression were the same as
described above for bacterial cultures (2.4 and 2.5).
2.7. Statistical analysis
For the growth rate comparisons of clinical specimens on different growth media, the Fischer
Yates method of estimating organism density was used (Fischer and Yates, 1963). Statistical
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analysis was performed by means of GraphPad InStat V3 ® using the Mann Whitney and
non-parametric ANOVA.
For the gene expression studies all tests were conducted in triplicate. Three cultures were used
at each time point. Gene copy numbers were determined in SDS 7000 software. Statistical
analysis was conducted using 9 datasets for each time point (i.e. 3 experimental sets of triplicate
data). InStat V3 using the Tukey Kramer Test or Student-Newman-Keuls Multiple
Comparisons Test and Repeated measures ANOVA. Additional statistical analysis was
performed using one way ANOVA, and the Bartlett test when indicated. Statistical definitions





S e c t i o n 3 : R e s u l t s
3. Results
3.1. Growth Density Comparison in Clinical Specimens
We measured the density of M. tuberculosis in sputum of 5 patients with active tuberculosis and
compared the values for growth obtained on the surface of agar plates incubated under aerobic
conditions and those in standing broth cultures where the organisms grow in an increasingly
oxygen depleted environment (Wayne and Hayes, 1996). The individual patient results are
shown in Table 3. There was no statistically significant difference in inter-patient variation (P =
0.30) on the plates or in the broth cultures at any of the points of observation.
Table 3. Organism density in sputum from 5 patients measured on agar plates and in broth
Week 3 Week 6 Week 8 Week 10
Plates Broths Plates Broths Plates Broths Plates Broths
Patient 1 1.931 3.573 1.931 3.573 2.237 4.573 2.573 4.931
Patient 2 3.237 5.573 4.573 7.237 4.573 7.237 4.573 7.237
Patient 3 4.237 5.237 4.573 6.237 4.573 6.237 4.573 6.237
Patient 4 3.237 3.237 4.573 5.237 4.573 6.931 4.573 7.237
Patient 5 4.237 4.931 4.573 4.931 4.931 7.573 4.931 7.573
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Figure 3.1 Mean Organism Density determined in clinical specimens by the Fischer Yates
Method
Growth on the surface of the plates continued till week 6, but came almost to a standstill
thereafter. Logarithmic growth in resting broth culture continued at least up till week 8. At the
next point of measurement 2 weeks later, only a slight increase was found. This could reflect a
further increase with a later decline or a stationary phase from week 8 onwards. Since broth
cultures that remain undisturbed for 6 weeks are thought to be oxygen depleted from 1 week
onwards, the continued growth in the broth is likely to represent growth of the anaerobic sub-
population.
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The Mann-Whitney test was used to determine if the difference in organism density between the
plates and the broth cultures was statistically significant at each time point. The results are given
in Table 4.
Table 4: P-values for significance in differences between the plates and broth cultures at
each time point.








P Value P= 0.0754 P=0.0476 P=0.159 P=0.004
3.2. Individual Gene Expression Results
Representative graphs and results are given here, from an experimental replicate of menB and
qcrB genes and the 16S quantities for the same run.
The standard curves for all genes in each experiment typically had an m value (gradient) of -3.3
with an R2 of 0.99 indicating that the data obtained was suitable for quantitative analysis
(detailed results for each gene including standard curves for each experiment shown in
Appendix B). A typical standard curve is represented below in Figure 3.2.1. Results generated
by the ABI 7000SDS are shown as sigmoidal amplification curves (Figure 3.2.2), or Threshold
cycle relative to well position. (Figure 3.2.3). This type of graph shows the similarity in
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threshold cycle of triplicate results and the equal spacing between threshold cycles of the
standard curve are an indication of the suitability of the data for quantitative analysis.
A detailed explanation of these graph types is given in Appendix A Section 7. Detailed real-
time PCR results and summary data are available in Appendix B. Detailed statistical analysis is
available in Appendix C. Aliquots of PCR products from representative wells in each
experiment were electrophoresed to ensure the visual confirmation of the presence of such
products. A typical agarose gel of electrophoresed end products is shown below in Figure 3.2.4.
and an example for each gene is given in Appendix D. This is not essential in real-ime PCR
employing Taqman® Chemistry as this type of probe ensures increased specificity in the
reaction. Agarose electrophoresis is a needed process in the event of using methods such as
SYBR green, as this method reports a signal in the presence of any double stranded DNA
formation including primer-dimer formation.
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Figure 3.2.1: Representative standard curve generated in quantitative real-time pcr by the
ABI 7000SDS
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Figure 3.2.2: Amplification curve generated in quantitative real-time pcr by the ABI
7000SDS
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Figure 3.2.3: Representative scatter plot of threshold cycle vs well position generated in
quantitative real-time PCR by the ABI 7000SDS
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Figure 3.2.4: Agarose Gel (2%) showing the presence of PCR products
68
3.3. 16S (rrs gene)
The copy number of the 16sR-RNA gene was used to allow metabolic gene activity to be
expressed per mycobacterial cell. Figure 3.3 shows the results as an average of 9
measurements at each time point with a 2-point moving average trend line indicated in
orange. Summarized experimental data and statistical data is available in Appendices B and C
respectively.
While there was a significant increase in the number of RNA copies over the first 9 weeks (p
< 0.0001), this slowed down afterwards, indicating decreased replication rates. The
expression of this gene represents the pattern of biomass of viable cells over the duration of
this experiment. The data implies a prolonged stationary-type growth phase under these
culture conditions.
Using repeated measures ANOVA it was determined that the P value is < 0.0001, considered
extremely significant. The significance in the variance of the means is summarised in Table 3.
The statistical analysis indicates that the variation among the column means is significantly
greater than expected by chance. In addition an assumption test showed that the matching was
effective. This test uses a second value of F and a different P value. F = 122.48 =
(MSindividual/MSresidual) as determined by the InStat Software. This P value is < 0.0001,
considered extremely significant. Effective matching (or blocking) results in significant
variation among means. With these data, the matching appears to be effective. Thus the
variation in data represented in Table 5 is extremely significant.
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Figure 3.3: Absolute quantification of 16S RNA (log and linear data) as an average of 9
experiments
0 3 6 8 9 10 11 12 13 14 15
average 1.76E+0 1.03E+1 7.42E+0 1.64E+1 1.59E+1 6.8E+09 1.72E+0 4.32E+0 4.53E+0 3.76E+0 1.08E+0








































Average (SEM) of 16s rRNA expression by Mycobacterium
tuberculosis H37Rv grown in undisturbed Middlebrook 7H9 broth
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Table 5: Comparison of the P-values showing a significance in the variation of the means at each time point
D0 Wk 3 Wk 6 Wk 8 Wk 9 Wk 10 Wk 11 Wk 12 Wk 13 Wk 14 Wk 15
D0 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Wk 3 <0.001 NS <0.01 <0.05 NS <0.001 <0.05 <0.001 <0.001 <0.001
Wk 6 <0.001 NS <0.01 <0.01 NS <0.001 NS <0.001 <0.001 <0.001
Wk 8 <0.001 <0.01 <0.01 NS <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Wk 9 <0.001 <0.05 <0.01 NS <0.01 <0.001 <0.001 <0.001 <0.001 <0.001
Wk 10 <0.001 NS NS <0.001 <0.01 <0.001 NS <0.001 <0.001 <0.001
Wk 11 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Wk 12 <0.001 <0.05 NS <0.001 <0.001 NS <0.001 <0.001 <0.001 <0.001
Wk 13 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 NS NS
Wk 14 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 NS NS
Wk 15 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 NS NS
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3.4. fdxA
The average ratio of expression of fdxA over 16s rRNA at baseline was -2.409. There was no
significant difference in this ratio up till 9 weeks of incubation (p > 0.05; Figure 3.4). This is the
period of rapid growth as shown in the 16s rRNA based growth curve (Figure 3.3). The
fdxA/rRNA expression ratio increased significantly between week 9 and 10 (p < 0.001) to a
level higher than those observed before this time point (p < 0.001). This was followed by a
decrease to baseline values at week 11 (p < 0.001) and an uninterrupted increase up till week
15. The rapid increase of fdxA expression between week 9 and 10 coincides with the start of the
decline phase in the mycobacterial growth curve (Figure 3.3) while the drop in fdxA expression
in week 11 precedes a growth spurt at week 12 (p < 0.001; Figure 3.4). The 2-point moving
average trend line, indicated by a solid black undulating line, indicates three cycles of dips and
peaks with an increase in peak levels over time, the highest peak appearing at the last stages of
incubation.
To reinforce the significance in the differences between the standard deviations an additional
test was performed. ANOVA assumes that the data are sampled from populations with
identical standard deviations. This assumption is tested using the Bartlett method. Bartlett
statistic (corrected) = 69.973. The P value < 0.0001 obtained through the Bartlett's test
suggests that the differences among the standard deviations are extremely significant.
The strong statistical data thus fortify that ferredoxin (fdxA) is an extremely significant
component in M. tuberculosis survival under challenge conditions.
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Figure 3.4: Mean gene expression ratios of fdxA/16S with 2-point moving average trend
line.
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mean
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Mean (SE) of fdxA/16s rRNA gene expression ratio over time by
Mycobacterium tuberculosis H37Rv in undisturbed Middlebrook 7H9
broth
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Table 6: Comparison of the P-values showing a significance in the variation of the means at each time point
fdxA DAY 0 WK 3 WK 6 WK 8 WK 9 WK 10 WK 11 WK 12 WK 13 WK 14 WK 15
DAY 0 NS NS NS NS <0.001 NS <0.001 <0.001 <0.001 <0.001
WK 3 NS <0.05 NS NS <0.001 NS <0.001 <0.001 <0.001 <0.001
WK 6 NS <0.05 NS NS <0.05 <0.05 <0.001 <0.001 <0.001 <0.001
WK 8 NS NS NS NS <0.001 NS <0.05 <0.001 <0.001 <0.001
WK 9 NS NS NS NS <0.001 NS <0.001 <0.001 <0.001 <0.001
WK 10 <0.001 <0.001 <0.05 <0.001 <0.001 <0.001 NS NS NS <0.05
WK 11 NS NS <0.05 NS NS <0.001 <0.001 <0.001 <0.001 <0.001
WK 12 <0.001 <0.001 <0.001 <0.05 <0.001 NS <0.001 NS NS <0.001
WK 13 <0.001 <0.001 <0.001 <0.001 <0.001 NS <0.001 NS NS NS
WK 14 <0.001 <0.001 <0.001 <0.001 <0.001 NS <0.001 NS NS NS
WK 15 <0.001 <0.001 <0.001 <0.001 <0.001 <0.05 <0.001 <0.001 NS NS
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3.5. menB
The gene expression levels, determined from the absolute quantities of menB relative to the 16s
rRNA at the different time points, are shown in Figure 3.5. There was an increase from baseline
till week 15 following an undulating pattern.
The initial 4.3 fold increase between baseline and week 6 (p < 0.001) was followed by a plateau
between week 6 and 10. This plateau was followed by a significant decrease over the next week
(p < 0.001) and a subsequent rise between week 11 and 13 (p < 0.001) and another area of
stability between week 13 and 15, hence showing an undulating pattern of expression in
standing liquid culture over 15 weeks. The relative gene expression indicated that at week 15
there was an 85.8 fold increase relative to day 0. The rise in gene expression over the last two
weeks of incubation was extremely significant relative to the earlier time points (P<0.001).
The 2-point moving average trend line represented as a blue dotted line, shows in a similar
fashion to the fdxA gene, a pattern of peaks and dips that repeats over the course of incubation
with the peak in absolute expression ratios seen in the final stages of incubation.
Both repeated measures ANOVA and one way ANOVA were conducted. The P value is <
0.0001 in both cases and thus extremely significant. Variation among column means is hence
significantly greater than expected by chance. In addition the Bartlett statistic (corrected) =
60.150 and the P value is < 0.0001. Bartlett's test suggests that the differences among the SDs is
extremely significant.
75
Figure 3.5 Absolute quantification of menB/16S RNA as an average of 9 experiments
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Mean (SE) Gene Expression Ratios of menB in M. tuberculosis H37Rv over 15
weeks in undisturbed Middlebrook 7H9 broth
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Table 7: Comparison of the P-values showing a significance in the variation of the means (menB) at each time point
menB DAY 0 WK 3 WK 6 WK 8 WK 9 WK 10 WK 11 WK 12 WK 13 WK 14 WK 15
DAY 0 NS <0.001 <0.001 <0.001 <0.001 <0.05 <0.001 <0.001 <0.001 <0.001
WK 3 NS <0.001 <0.05 <0.01 <0.001 NS <0.001 <0.001 <0.001 <0.001
WK 6 <0.001 <0.001 NS NS NS NS NS <0.001 <0.001 <0.001
WK 8 <0.001 <0.05 NS NS <0.05 NS NS <0.001 <0.001 <0.001
WK 9 <0.001 <0.01 NS NS NS NS NS <0.001 <0.001 <0.001
WK 10 <0.001 <0.001 NS <0.05 NS <0.001 NS NS NS <0.001
WK 11 <0.05 NS NS NS NS <0.001 <0.01 <0.001 <0.001 <0.001
WK 12 <0.001 <0.001 NS NS NS NS <0.01 <0.05 <0.05 <0.001
WK 13 <0.001 <0.001 <0.001 <0.001 <0.001 NS <0.001 <0.05 NS NS
WK 14 <0.001 <0.001 <0.001 <0.001 <0.001 NS <0.001 <0.05 NS <0.05
WK 15 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 NS <0.05
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3.6. sdhA and frdA
Figure 3.6: Gene Expression ratios of TCA components sdhA and frdA over 15 weeks
Figure 3.6 also shows the levels of expression of sdhA, frdA determined from absolute
quantities of each gene as a ratio of the 16S quantity at each respective time point. The
expression ratio of both TCA genes increased over time. The expression levels of these
genes in the last period of incubation were significantly higher as compared to the early
stages (p < 0.001). Within the first three weeks of incubation we see a decline in the
expression levels of the aerobic sdhA and a slight increase in the anaerobic frdA. However
throughout the rest of the incubation period, the expression patterns of each gene are nearly
identical. The expression of both genes at week 6 increases significantly to week 3
although, no increased expression was observed between week 6 and 10, but there was a
0 3 6 8 9 10 11 12 13 14 15
frdA -2.735 -2.69 -2.093 -2.411 -2.359 -2.013 -2.799 -2.048 -1.509 -1.473 -1.636















Succinate dehydrogenase (sdhA) and fumarate reductase (frdA) gene
expression by Mycobacterium tuberculosis H37Rv relative to 16s (log 10)
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significant decline in the next week (p < 0.001). A further significant increase in expression
of both genes between weeks 13 and 15 was noted. At this late stage of incubation the
absolute gene expression ratios are at their highest when compared to the rest of the
incubation period. The two point moving average trend lines, shown as yellow (sdhA) and
blue (frdA) solid lines, indicate a similar increase in undulating fashion as observed for the
other genes.
In the case of frdA repeated measures ANOVA and the Student-Newman-Keuls Multiple
Comparisons Test were used to determine the statistical significance of the difference in
mean gene expression data between each time point. The repeated measures ANOVA
indicates the P value is < 0.0001, considered extremely significant and variation among
column means is significantly greater than expected by chance. Assumption test: To
determine if the matching was effective another test using a second value of F and a
different P value was run. F = 67.168 =(MSindividual/MSresidual) The P value is <
0.0001, considered extremely significant thus effective matching or blocking results in
significant variation among
means. With these data, the matching appears to be effective.
The same statistical analysis was applied to the sdhA data (i.e. repeated measures ANOVA
and Student-Newman-Keuls Multiple Comparisons Test). The repeated measures ANOVA
once again designated that the P value is < 0.0001, and extremely significant. Variation
among column means in this case is also significantly greater than expected by chance.
Assumption test: The matching efficacy in this case, again using a test that uses a second F
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value and a different P value. F = 38.783 = (MSindividual/MSresidual) the P value is <
0.0001, considered extremely significant. Effective matching (or blocking) results in
significant variation among means. With these data, the matching appears to be effective.
The Bartlett test (corrected) = 3.696 with a P value of 0.9600, however suggests that the
differences among the SDs is not significant in the case of frdA. In the case of sdhA, the
Bartlett statistic (corrected) = 4.541 with a P value of 0.9196. Bartlett's test suggests that
the differences among the SDs are again not significant.
Table 8 : Comparison of the P-values showing a significance in the variation of the means at each time point














NS <0.001 <0.01 <0.001 <0.001 NS <0.001 <0.001 <0.001 <0.001
WK 3 NS <0.001 <0.05 <0.01 <0.001 NS <0.001 <0.001 <0.001 <0.001
WK 6 <0.001 <0.001 <0.01 NS NS <0.001 <0.01 <0.001 <0.001 <0.001
WK 8 <0.01 <0.05 <0.01 NS <0.001 <0.001 <0.01 <0.001 <0.001 <0.001
WK 9 <0.001 <0.01 NS NS <0.01 <0.001 <0.05 <0.001 <0.001 <0.001
WK
10
<0.001 <0.001 NS <0.001 <0.01 <0.001 NS <0.001 <0.001 <0.001
WK
11
NS NS <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
WK
12
<0.001 <0.001 <0.01 <0.01 <0.05 NS <0.001 <0.001 <0.001 <0.001
WK
13
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 NS NS
WK
14
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 NS NS
WK
15
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 NS NS
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Table 9 Comparison of the P-values showing a significance in the variation of the means at each time point















NS <.0.01 NS NS <0.001 NS <0.001 <0.001 <0.001 <0.001
WK 3 NS <0.001 <0.001 <0.01 <0.001 NS <0.001 <0.001 <0.001 <0.001
WK 6 <.0.01 <0.001 NS NS NS <0.001 NS <0.001 <0.001 <0.001
WK 8 NS <0.001 NS NS <0.01 <0.001 <0.05 <0.001 <0.001 <0.001
WK 9 NS <0.01 NS NS <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
WK
10
<0.001 <0.001 NS <0.01 <0.001 <0.001 NS <0.05 <0.01 NS
WK
11
NS NS <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
WK
12
<0.001 <0.001 NS <0.05 <0.001 NS <0.001 <0.01 <0.01 <0.05
WK
13
<0.001 <0.001 <0.001 <0.001 <0.001 <0.05 <0.001 <0.01 NS NS
WK
14
<0.001 <0.001 <0.001 <0.001 <0.001 <0.01 <0.001 <0.01 NS NS
WK
15
<0.001 <0.001 <0.001 <0.001 <0.001 NS <0.001 <0.05 NS NS
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3.7. qcrB
The qcrB gene product shows a similar pattern of absolute gene expression over the incubation
period as the rest of the genes, with a sharp increase in expression levels towards the end of
incubation (Figure 3.7). The relative expression levels early in incubation are not statistically
significant (P> 0.05) until week 10 (Table 10). This is surprising as the qcrB gene is reported to
code for a product that has a function in aerobic respiration, which would presumably be
dominant over the early stages of incubation.
Both one way and repeated measures ANOVA capitulate a P value is < 0.0001, considered
extremely significant thus again, the variation among column means is significantly greater than
expected by chance. ANOVA assumes that the data are sampled from populations with identical
SDs. This assumption is tested using the method of Bartlett. Bartlett statistic (corrected) =
111.68. The P value is < 0.0001. Bartlett's test suggests that the differences among the SDs is
extremely significant.
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Table 10: Comparison of the P-values showing a significance in the variation of the means at each time point
qcrB DAY 0 WK 3 WK 6 WK 8 WK 9 WK 10 WK 11 WK 12 WK 13 WK 14 WK 15
DAY 0 NS NS NS NS <0.001 NS <0.001 <0.001 <0.001 <0.001
WK 3 NS <0.01 NS NS <0.001 NS <0.001 <0.001 <0.001 <0.001
WK 6 NS <0.01 NS NS NS NS NS <0.05 <0.001 <0.001
WK 8 NS NS NS NS NS NS NS <0.001 <0.001 <0.001
WK 9 NS NS NS NS NS NS NS <0.001 <0.001 <0.001
WK 10 <0.001 <0.001 NS NS NS <0.001 NS NS NS <0.001
WK 11 NS NS NS NS NS <0.001 <0.01 <0.001 <0.001 <0.001
WK 12 <0.001 <0.001 NS NS NS NS <0.01 NS NS <0001
WK 13 <0.001 <0.001 <0.05 <0.001 <0.001 NS <0.001 NS NS NS
WK 14 <0.001 <0.001 <0.001 <0.001 <0.001 NS <0.001 NS NS <0.05
WK 15 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0001 NS <0.05
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Figure 3.7 Summary of qcrB gene expression
Day 0 Week 3 Week 6 Week 8 Week 9 Week 10 Week 11 Week 12 Week 13 Week 14 Week 15



























Mean (SE) Gene Expression Ratios of qcrB in M. tuberculosis
H37Rv over 15 weeks in undisturbed Middlebrook 7H9 broth
weeks of incubation
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3.8. Summary of results and trends of all genes
Figure 3.8.1 Gene expression pattern over 3 weeks of incubation.
In Figure 3.8.1 above, we see the the gene expression trend over 3 weeks in standing liquid
culture. At this stage it appears that some genes are distinctly upregulated, while others are














































Expression of ETC components over time for M. tuberculosis
H37Rv grown in static liquid culture
fdxA Mean frdA sdhA mean Mean menB Mean qcrB 16S Mean
85
Figure 3.8.2: Gene expression pattern over 6 weeks of incubation.
Figure 3.8.2 illustrates that at 6 weeks however, this trend is subdued by an upregulation in
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Figure 3.8.3 Gene expression patterns over 10 weeks of incubation.
At 10 weeks in sealed culture we expect that the cells will be shutting down due to an
accumulation of toxic metabolites and depleted oxygen. However we see an unexpected
upregulation of all genes expressed (Figure 3.8.3). At this point all gene expression levels are
highly significant relative to day 0 and week 3. It is noteworthy that an earlier experiment












































Expression of ETC components over time for M. tuberculosis
H37Rv grown in static liquid culture
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Figure 3.8.4 Complete summary of experimental data.
On further examination, we see a sharp drop in expression levels between weeks 10 and 11
for all selected genes. .The decrease is extremely significant and it precedes an increase in
16S quantities between weeks 11 and 12, that is extremely significant (P<0.001). The
expression of these genes at weeks 13, 14 and 15 is extremely significant relative to the earlier
timepoints (P<0.001). In addition the decrease in 16S between weeks 12 and 13 is statistically
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Figure 3.8.5: Comparison of Gene expression ratios between weeks 14 and 15
A closer look at weeks 14 and 15 shows that there exists a similar situation relative to weeks 0
and 3, where there is a difference in the up and downregulation of selected genes. This
implies the start of yet another cycle of increased expression of ETC components as a means
to survive.
The relative gene expression results presented in Figure 3.8.6 were obtained by dividing the
gene expression ratio at each time point by the gene expression ratio obtained at day 0 for that
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Figure 3.8.6 Relative quantitation of each gene relative to its own day 0
The relative expression graphs visually clarify why the Bartlett test for sdhA and frdA indicated
that the variation in the means was not as significant as observed for the other 3 genes. The













Gene Expression ratios for each gene relative to Day 0
qcrB sdhA menB frdA fdxA
D0 Wk 3 Wk 6 Wk 8 Wk 9 Wk 10 Wk 11 Wk 12 Wk 13 Wk 14 Wk 15
qcrB 1.00 0.61 2.49 1.72 1.57 4.87 1.05 4.65 9.79 16.37 78.03
sdhA 1.00 0.73 43.09 2.04 1.76 6.34 0.56 5.07 12.80 13.57 10.85
menB 1.00 1.26 4.30 3.26 3.59 8.14 2.34 6.63 17.49 17.21 85.78
frdA 1.00 1.17 4.47 2.10 2.80 8.39 1.03 6.06 19.48 23.67 13.63
fdxA 1.00 0.76 2.04 1.32 0.97 5.00 0.77 3.51 7.61 7.19 76.46
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expression levels. The menB and qcrB genes also showed similar extremes in upregulation at
week 15 with an 85.78 and a 78.03 fold increase respectively.
3.9. RNA quantitation and 16S RNA gene detection in sputum specimens
Table 10 shows the quantities of RNA in five sputum specimens of different patients. The
amounts obtained ranged from 129 to 434 ng/µL. The variation in the concentration of cDNA
obtained from identical amounts of RNA (2µg) indicates inhibition of the reverse
transcription process.











1 434.78 4.60 98.80
2 204.08 9.80 133.50
3 270.27 7.40 113.40
4 285.71 7.00 111.40
5 129.87 15.40 215.50
The amounts of 16s RNA as well as the amounts of mRNA coding for the different components
of the metabolic pathways studied are shown in Table 12 as number of amplicons/mL. As to be
expected, broad variation between specimens is seen with all.
91
Table 12 : Amplicon quantities per 1000 µL
Specimen 16s frdA fdxA menB qcrB sdhA
1
88.89 358406.22 21294.22 86345.78 88.89 88.89
2
552.89 456078.22 53247.11 108077.33 53426.67 3750.22
3
88.89 17068.44 2728.89 22289.78 31487.11 135.11
4
88.89 88.89 6448.89 4255.11 88.89 1331.56
5
344.00 88.89 11915.56 16402.67 188.44 88.89
Average 232.71 166346.13 19126.93 47474.13 17056.00 1078.93
Assuming that the level of inhibition was similar for all primer sets, the amount of amplicons
obtained can be compared with each other. The highest number was found with fdxA, frdA and
menB amplicons while sdhA showed the lowest numbers. Although the average for qcrB was







The claim that M. tuberculosis is a facultative instead of a strict aerobic species is based on
observations that the organism is susceptible to metronidazole and that its growth is enhanced
by agitation in subcultures of the bacteria but not clinical specimens. Furthermore, the genes
coding for anaerobic pathways have been identified in the H37Rv genome. Metronidazole is a
pro-drug that is activated via the transfer of a single electron from ferredoxin to the nitro group
of the drug, resulting in the formation of a free radical (Quon D et al, 1992). Therefore,
metronidazole is exclusively active against microbes that use the fermentative pathway of
metabolism. Metronidazole has been found to kill dormant cells of M. tuberculosis in vitro but
it has no activity against actively dividing M. tuberculosis cells (Wayne and Sramek, 1994),
suggesting the dormant state to be equivalent with anaerobic metabolism.
The work presented in this thesis shows that the number of organisms in sputum of patients
with active pulmonary tuberculosis capable of growing in oxygen depleted Middlebrook broth
outnumbers those that grow on the surface of Middlebrook agar plates in the presence of
oxygen. It also shows variations in gene expression when grown under oxygen limiting
conditions during a prolonged incubation period. These results support the claim that M.
tuberculosis is a facultative organism.
Wayne and Hayes (1996) observed in undisturbed sealed broth cultures that the organisms went
from aerobic metabolism through a micro-aerophilic stage into anaerobic metabolism in which
no replication was observed. This differs from our first set of experiments with sputum from
patients with active pulmonary tuberculosis. Wayne and Hayes inoculated mycobacterial
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cultures grown aerobically into the broth while we inoculated the broths directly with sputum.
Our results indicate that a significant part of the mycobacterial population in the lungs of
patients with TB is formed by an anaerobic fraction that is replicating. Our observations based
on quantitative growth of M. tuberculosis with and without oxygen directly from sputum, are
corroborated by the gene transcription experiments in sputum. The genes with highest level of
transcription were the genes coding for components involved in anaerobic metabolism.
Oxygen saturation has shown to approach 0 % at approximately 8.3 days (200 hrs) of
incubation (Wayne and Hayes, 1996). From this it follows that at our first point of measurement
(21 days) there was full oxygen depletion. This suggests that the observed organism density in
broth resulted from anaerobically metabolizing organisms only. The observed non-replicating
state (NRP1 and NRP2) of M. tuberculosis has been clearly demonstrated in vitro but this seems
not to correlate with in vivo conditions. Heifets, et al (2005) reported on the effect of drugs on
organisms in the non-replicating state in vitro. Their study assumes that the NRP state reflects
dormancy in vivo. Our work on sputum specimens indicates that this might not be the case.
The methodology used to quantify growth from sputum makes a day 0 observation futile since
in vitro growth has not occurred as yet. However, the graph (Figure 3.1) suggests the presence
of large numbers of M. tuberculosis cells metabolizing anaerobically at that point. At all time
points the number of anaerobically metabolizing cells outnumbered the aerobic ones although,
as to be expected, the replication is slower anaerobically than aerobically. This difference
became statistically significant at week 6 (p=0.0476) and increased in signicance at week 10 (p=
0.004).
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Dhillon , et al (2004) conducted similar research, where they compared the growth density in
broth and the growth on plates in tissue from mice with a 7-day old acute M. tuberculosis
infection with that in mice with a chronic 10-month old infection. The ratio of growth in broth
over that on plates was significantly higher in the latter group. Our results in the culture
experiments with clinical specimens, were quantitatively similar to the results obtained from the
murine experiments conducted by Dhillon, et al (2004) in which they demonstrated the
difference in organism densities using acute and chronic infectious organisms. The observations
of Dhillon, et al (2004) concur with our findings. Our patients are likely to harbour
microorganisms that are similar in physiological state to those in the mice with a 10-month old
infection.
This part of our study indicates that in patients with active pulmonary tuberculosis, a large
fraction of M. tuberculosis cells is anaerobically metabolizing. These organisms replicate in
vivo in oxygen depleted conditions and are therefore not identical with dormant M. tuberculosis
as defined in terms of hypoxic conditions conferring non-replicating persistence.
If a proportion of mycobacteria in active tuberculosis are in the anaerobic mode, metronidazole
could be a useful adjunct to the treatment, particularly when therapeutic choices are limited as
in cases with extensive drug resistance. However, the therapeutic effect of metronidazole is
difficult to measure. Treatment of tuberculosis in humans is by means of a combination of a
minimum of 3 drugs. Studies that measure the effect of single drugs over a period of 2 months
are therefore impossible. The Early Bactericidal Assay (EBA) measures the effect of
metronidazole and its derivatives in human pulmonary tuberculosis over a period 3 to 5 days
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and has been accepted as a predictor of therapeutic effect when used in multidrug regimens.
This test measures the decline of the rapidly multiplying fraction of mycobacteria (Jindani, et al,
1980). As this fraction has a down regulated fdxA expression, the EBA cannot be used to
measure the effect of metronidazole and its derivatives.
The results from the first set of experiments suggest that in vitro dormancy models are not
representative of the in vivo conditions in patients with tuberculosis. Therefore, gene expression
studies should preferably be done on bacteria in clinical specimens without growing them first
in vitro. However, there is still value in studying gene expression in cultures containing
organisms that do not replicate. This can tell us whether these nonreplicating cells are
metabolically active or in a non-metabolic state like bacterial spores. We therefore studied
expression levels of a selected number of genes coding for products known to play a role in
aerobic as well as anaerobic metabolism. We used the H37Rv strain grown in standing liquid
cultures, as described in the Wayne Model.
The Wayne model of nonreplicating persistence shows that, when M. tuberculosis is grown in
unagitated liquid culture media, it adjusts to a state of equilibrium, where cells remain viable but
are not actively dividing. He rationalizes this model of gradual oxygen depletion, by explaining
that M. tuberculosis in the host will initially be exposed to oxygenated alveoli, and subsequently
to conditions that become increasingly hypoxic (Wayne and Lin, 1982). Thus the organism
would have to undergo a gradual adjustment to increasing oxidative stress. The un-agitated
liquid culture model serves to represent such conditions of gradual oxygen depletion and is
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widely reported on as a demonstration of the organism’s resilience. The genes we studied were
fdxA, menB, frdA, sdhA and qcrB.
The ferredoxin coding gene fdxA is in M. tuberculosis part of the DosR regulon, also known as
the dormancy regulon, which is upregulated by oxygen depletion under in vitro growth
conditions (Voskuil, 2004). Our fdxA expression results (Fig 3.4) show that the bacteria
produce minimal amounts of ferredoxin while in the phase of rapid replication. Since the culture
media were left undisturbed in a sealed tube, there was a systematic deterioration of conditions
for aerobic growth, due to depletion of nutrients and oxygen and accumulation of toxic
metabolites. As a result, the culture went from the log phase into the stationary phase after 3
weeks followed by the decline phase starting at week 9. The bacteria responded to this by a
sudden increase in the expression of ferredoxin as measured at week 10. The growth spurt
observed at week 12 (Figure 3.3) was preceded by a decline in ferredoxin expression. This
underscores the notion that ferredoxin expression is associated with a decline in the speed of
replication. It seems that fdxA expression is reciprocally associated with speed of replication. In
facultative bacterial species the speed of replication is associated with aerobic and anaerobic
metabolism with the slowest replication under anaerobic circumstances. Our results suggest that
this is also the case with M. tuberculosis since fdxA expression is associated with anaerobic
metabolism.
The decrease in multiplication rate at week 11 precedes an increase in the fdxA expression
which from there increased slowly but steadily till the end of the incubation period. During that
time the number of bacterial cells remained low. This contradicts the assumption that the cells
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arrest all activity under circumstances where there is a systematic depletion of oxygen and
nutrients. This challenges the concept that the organism becomes dormant like bacterial spores.
It seems to merely change to anaerobic metabolism which results in a decrease in
multiplication. Since the species multiplies under aerobic conditions once per 18 to 24 hours, a
multiplication event under anaerobic conditions will take several days. As a result, increase in
cell numbers under anaerobic conditions will be difficult to measure.
Upregulation of the fdxA gene should render the microbe susceptible to metronidazole. This
susceptibility has been shown in vitro, but has not been observed in the mouse aerosol or the
mouse hollow fiber model (Klinkenberg , et al, 2008). Information on activity of metronidazole
on M. tuberculosis in the human host is not available. The consistent presence of the fdxA
mRNA in the sputum of all five patients studied suggests that this drug must be able to
contribute to successful treatment of patients with tuberculosis.
Other support for the hypothesis that M. tuberculosis can switch to anaerobic metabolism comes
from our observations on menB transcription. The enzymes involved in the menaquinone
pathway are not produced by human cells and therefore naphthoate synthase has already been
identified as a potential drug target (Truligo, et al, 2003). In un-agitated broth cultures, the
bacteria undergo multiple challenges due to changes in the media over the incubation period.
The cells face a gradual depletion of oxygen as the tubes remain sealed throughout the
experiment. In addition there is a depletion of nutrients and an accumulation of toxic metabolic
intermediates as media is not replenished. Under these conditions, one would expect the cells to
systematically shut-down their metabolic processes. However, there is an increase in relative
gene expression of menB with the highest expression levels shown in weeks 13-15. Since the
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enzyme activity is normalized against ribosomal RNA gene expression, the data reflect
increased enzyme expression at cellular level and is not a reflection of the increase in cell mass.
The decrease of menB expression at week 11 may be due to the depletion of succinyl benzoyl-
CoA which is the substrate for naphtoate synthase (Figure 1.3). It is also possible that feedback
inhibition occurs due to the accumulation of the end product menaquinone. The steady increase
in menB expression over time appears to serve the purpose of adjusting to a corresponding
increase in oxidative stress. Our observations therefore further reinforce the concept that M.
tuberculosis shifts to an anaerobic mode of metabolism when depleted of oxygen and should
therefore be classified as a facultative rather than a strict aerobic organism. Further exploration
of the menB gene product as drug target is thus warranted. Naphthoate synthase is a key
enzyme in the production of menaquinone. It has been reported that menaquinone is
predominant under anaerobic culture conditions in E. coli, with the presence of little
ubiquinone, and the opposite is found under aerobic conditions (Soballe and Poole, 1999). In
prokaryotes, it also plays an important role in the anaerobic biosynthesis of pyrimidines (Gibson
and Cox, 1973).
The TCA cycle is a core intermediary metabolic pathway and plays an important role in many
biosynthetic processes by providing intermediates for other reactions. Although the TCA cycle
is predominant in eukaryotic cells, it seldom presents in bacteria. Gene sequencing has revealed
that M. tuberculosis possesses a complete set of genes for the tri-carboxyl acid (TCA) cycle
(Cole, et al, 1998). While little is known about the metabolic mechanisms employed by M.
tuberculosis in vivo, there have been reports on modifications to the TCA cycle that might
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explain its persistence in macrophages (Munoz-Eliot and Mckinney, 2006). In mycobacteria,
the TCA cycle functions in either reductive or oxidative processes, depending on the availability
of nutrients and energy sources. It has been shown that isocitrate lyase and glyoxylate
dehydrogenase, two enzymes of the glyoxylate shunt, are activated during adaptation to oxygen
limited conditions (Wayne and Lin, 1982), and isocitrate lyase expression is enhanced during
intracellular metabolism in macrophages (Honer et al, 1999).
The TCA cycle plays a central role in microbial survival in hostile environments that are
nutrient-starved and oxygen-depleted (Hagerhall, 1997; Voskuil et al, 2004; ,Wayne and
Sohaskey, 2001). We report on the expression of the succinate dehydrogenase (sdhA) and
fumarate reductase (frdA) genes in M. tuberculosis undergoing gradual starvation and oxygen
depletion.
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Figure 4.1 Schematic Overview of the forward and reverse TCA cycle with the Glyoxalate
Shunt in the oxidative cycle
Conversion of Succinate to Fumarate in the Forward/Oxidative TCA by Succinate
Dehydrogenase
Conversion of Fumarate to Succinate in the Reverse/Reductive TCA by Fumarate
Reductase
Direct Conversion of Isocitrate to Malate indicating the Glyoxalate Shunt
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Fig. 4.1 shows the forward and reverse cycles of the TCA cycle. Succinate dehydrogenase and
fumarate reductase are key enzymes in this cycle. They are protein complexes that are similar
both in composition and in subunit structure. The former catalyzes the conversion of succinate
into fumarate while the latter catalyses the reverse reaction (Ackrell et al, 1992). Succinate
dehydrogenase plays a role in the aerobic respiratory chain (Hagerhall, 1997) and fumarate
reductase catalyzes the final step in anaerobic respiration (Kroger, 1978). These enzymes
therefore allow adaptation to specific environments. These enzymes thus represent potential
markers of aero- and anaerobiosis in vivo.
As sdhA expression is associated with the aerobic, oxidative direction of the TCA pathway, one
would expect an opposite trend as compared to frdA. This was the case in the first 3 weeks of
the experiments (Figure 3.6 and Figure 3.8.1). However, later on the results show near equal
levels of gene expression indicating similar conversion rates of succinate to fumarate and vice
versa. At the first point of measurement the media is already depleted of oxygen (Wayne and
Hayes, 1996). This suggests that in M. tuberculosis in the absence of free oxygen, there is still a
need for succinate dehydrogenase. Since it is know that fumarate can serve as an electron
acceptor under anaerobic conditions, the action of the succinate dehydrogenase enzyme may
indeed be required.
It was demonstrated that in Escherichia coli under anaerobic conditions, the succinate
dehydrogenase complex functionally replaces the fumarate reductase complex (Makalashina et
al, 1998). It was found that under anaerobic circumstances both enzyme complexes were
similarly expressed. Thus, the similar function of succinate dehydrogenase under anaerobic
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conditions in M. tuberculosis is not unique. This further implies that this gene pair does not
function as a suitable marker for aero- and anaerobiosis in vivo as they both show similar
expression patterns under oxygen depletion.
Our observations suggest that in the absence of oxygen, M. tuberculosis cells go through phases
of high metabolic activity with deceleration in between. Cells in older cultures up till week 15
show higher metabolic activity than cells in younger ones. Our data indicate that succinate
dehydrogenase may have a dual role as described for E. coli. Further to the above, a component
of the fumarate reductase has been theoretically indicated as drug target in M. tuberculosis
(Anishetty et al, 2005). Although the expression pattern in vitro indicates that succinate
dehydrogenase may have a dual role, the in vivo detection of the TCA transcripts identifies frdA
as a potential drug target. The Bartlett statistics indicate that the differences in the standard
deviations for sdhA and frdA are, in statistical terms, not more significant than can be expected
by chance. This implies that it has a more consistent role in cellular process than the other genes
investigated. While there is an increase over time, the level of increase is not as significant as
observed for the menB, fdxA and qcrB genes.
The operation of the glyoxalate bypass (Figure 4.1) implies that the enzymatic conversions of
isocitrate to malate in the TCA can be circumvented (Wayne and Lin, 1982). However it
appears that in M. tuberculosis the direct conversion from isocitrate to malate may occur in
parallel with the enzymatic conversions in between, giving rise to a two-dimensional TCA.
Further studies into the role of the TCA in mycobacterial survival and persistence are
warranted.
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The qcrB gene is reported to code for a product that is involved in aerobic processes. The
experimental data (Figure 3.7) indicates a similar pattern of expression to that of the other genes
with a peak in expression towards 15 weeks of incubation, when conditions within the culture
vessel would have been most hostile. One would have expected to see a decrease in the
expression of the qcrB gene over time, with the corresponding increase in that of menB. These
results therefore indicate that that the qcrB gene may not function exclusively under aerobic
conditions.
While expression of sdhA and frdA is part of the same pathway, the menB and qcrB genes are
not directly linked. The menB gene codes for an enzyme that leads to the formation of the
membrane found menaquinone, while the qcrB gene codes for the cytochrome component of
the membrane bound ubiquinone cytochrome B reductase complex. Little is currently known
about the particular role of this complex in mycobacteria. Matsoso and colleagues reported in
1998 that M. smegmatis strains with mutations in the bc1 complex and in subunit II of
cytochrome c oxidase were found to be profoundly growth impaired, confirming the
importance of this respiratory pathway for mycobacterial growth under aerobic conditions.
However, even when knockout experiments on the qcrB and related genes to establish the role
of other cytochrome components in aerobic growth were carried out, growth did not completely
cease. This implies that if the cytochrome b reductase complex is inhibited under anaerobic
conditions, there are alternative means of electron transport, and thus growth of mycobacteria
under these conditions. This supports the switch from aerobic to anaerobic metabolism.
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Early work indicates that there may be a link between the b-type cytochromes and succinate
dehydrogense. In a study on the relationship between the iron containing enzymes of
Corynebacterium diphtheriae and diphtheria toxin, Pappenheimer and Hendee (1947) obtained
evidence that cytochrome b was “directly concerned in the oxidation of succinate”. They were
unable to separate succinate dehydrogenase from cytochrome b by differential centrifugation.
Structural genes encoding quinol-cytochrome c reductase (Qcr) were cloned and sequenced
from the Rhodococcus rhodochrous. The genes qcrC and qcrA encode diheme cytochrome c
and the Rieske Fe–S protein, respectively, while the qcrB product is a diheme cytochrome b.
These amino acid sequences are similar in Corynebacterium and Mycobacterium (Sone, et al,
2003). Although it seems that the qcrB gene product in mycobacteria is not a potential drug
target, it may still have other applications. It is used as a phylogenetic marker, though mainly in
eukaryotic cells, where it is found in the mitochondria. Since there is an evolutionary link
between bacteria and mitochondria, there may be scope for this type of application with
mycobacteria. This concept has not yet been explored, but there are reports on the use of b-type
cytochromes for the rapid identification of mycobacterial species using real-time PCR and
DNA-microarrays (Tobler, et al, 2006).
Our gene expression studies in the un-agitated broth culture model differ from other studies in
that the incubation time is significantly prolonged. However, Corper and Cohn reported as
early as 1933 that viable cells of M. tuberculosis were detected in a sealed standing culture tube
after 12 years. By comparison the upregulation of electron transport genes at 13-15 weeks is
hardly stirring. However, we still need to be able to explain the dynamic behind this growth
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phenomenon. Since these observations are unique to liquid culture, the following discussion
focuses on the chemical nature of water.
It has been reported that due to the clumping tendency of H37Rv, the number of colony forming
units on solid agar may be artificially reduced (Zhang, et al, 1998).
They also report that the phenomenon of clumping is far more prevalent in the H37Rv strain
when compared to the H37Ra. In order for a bacterial clump to be visible to the naked eye, it
must consist of millions of cells compacted to form what is perceived as floccules suspended in
culture. It is possible that the clumping of these cells is a frontline survival strategy of the
tubercle bacilli.
Theoretically, the single cell of Mycobacterium tuberculosis is reported to be approximately 2-
4um in length with a cylindrical diameter of 0.2-0.5µm. A visible clump of, hypothetically,
2mm diameter would have a total surface area of 12571429 µm as determined by the formula
4πr2. The surface area of a bacterium of average length and diameter of 3µm and 0.35µm 
respectively would be 7.37µm; determined by the formula 2πr2 +2πrh. That would make the 
clump consist of just fewer than 2 million cells. While it is assumed by many that the cells
having gone through several orders of binary fission are all similar in physiological state, this
cannot theoretically be the case. Figure 4.2 illustrates a clump that was observed in a cell
suspension that was vortexed for 30 seconds on maximum speed, and provides a visual
demonstration of the clumping concept. While clumping in culture is visible to the naked eye,
the aggregate illustrated was only visible under oil emersion.
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Within a biofilm, different microorganisms co-exist in equilibrium with one another, each
having a different function in maintaining the homeostatic nature of the film. The cells at the
core of the biofilm are protected from exposure to its outermost conditions. The nutrient content
is regulated and of course the redox potential will differ from the core of the biofilm moving
outwards. To expand this concept even further, cells at the core of a clump are protected from
physical contact with antibiotics and further potentially toxic intermediates. Even in the host
when being engulfed by phagocytes, the outermost cells in a clump may well be able to
communicate to cells at the core, inducing factors (known and unknown) to be expressed that
aid in its survival. While this exercise (visualizing clumps) is simplistic in its design and nature,
it emphasizes a key concept in further decrypting the survival mechanisms of M. tuberculosis.
Figure 4.2: Ziehl Neelsen Stain showing clump formation in M. tuberculosis H37Rv
The co-expression of aerobic and anaerobic components may thus be a very deliberate survival
strategy of the microorganism. Gause’s law of competitive exclusion, states categorically that
where two species coexist in the same environment, there will ultimately be a dominance of the
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one species over the other. In other words one species will out-compete the other for essential
nutrients etc. This however refers to different species. It is possible that a similar intra-species
situation would occur within a sealed tube, where you would see a dominance of the anaerobic
fraction over the aerobic. Based on both the phenotypic and genomic observations in liquid
culture under gradual oxygen depletion, there appears to be a type of co-operation between the
different populations that ultimately forms a formidable survival strategy for the organism.
It is thus possible that the dynamic within the clump can offer cells a level of protection in the
host. This protective phenomenon is observed elsewhere in nature as is the case for bacteria
within a biofilm. This phenomenon can be theoretically compared to the cellular dynamic
within a biofilm. Pseudomonas syringae for example, is reported to have augmented survival
on leaf surfaces in aggregates when compared to individual cells (Monier and Lindow, 2003).
It is also known that spatial distribution of cells, specifically in aggregates, is invariably
influenced by the conditions of the environment, with particular emphasis on survival of cells in
clumps (Wilson et al, 2004). While the concept of cellular survival by aggregation or biofilm
formation is well known, this concept has not been studied sufficiently in Mycobacterium
tuberculosis. It is noted however that Thornton and colleagues (1996) describe mucus formation
in the respiratory tract as a biofilm.
Bull reported as early as 1915, that aggregation of cells s of typhoid and dysentery bacilli
agglutinate more immediately upon entering the circulatory system of rabbits (Bull, 1916).
Virulent pneumonococci did not agglutinate upon introduction into the rabbit circulatory
system, however they did form aggregations after intravenously introducing specific immune
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sera (Bull, 1916). Although they state that clumping in vivo ensures rapid elimination of the
cells from the bloodstream, they imply that these clumps may actually accumulate in organs due
to their rapid removal from circulation. Contrary to the role of the clump in virulence though,
they state that single cells are actually more likely to persist as it may be easier for single cells
to evade phagocytosis. However, single cells may be more prone to the action of complement
activation. It is well conceptualized that cells at the core of a biolfim formation are safely
shielded from harsh conditions in the environment, including a shift in conditions and lethal
substances.This may explain why differential gene expression results are seen in experiments
are carried out on the laboratory strain H37Rv. Further to the above, it appears that this
stratification in physiological states is a mechanism of survival. The cells operate in a
synergistic manner, possible supplying other cells with essential components and facilitating
long term survival by providing a protective effect. The biofilm concept can be further
extended to include sputum specimens. The glycopeptide structure of sputum is comparable to
the matrix of a biofilm. The laws of thermodynamics, tell is that in an isolated system the total
amount of energy is conserved though it may change from one form to another. Even in
chemical reactions, with the transfer of energy, the number of atoms and sub-atomic particles is
precisely conserved on either side of a reaction. In the application of this law to biological
systems, the impact at the cellular level is not that obvious. Many reactions generate heat as
well as chemical products. Since it is a closed system, over time, the total energy in the system
is conserved and that is what ultimately enables the organisms to survive. There may be an issue
of nutrient depletion, but that energy is still present in the cellular environment, in the form of
ready made enzyme complexes (possibly from dead cells) and cellular components that may be
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assimilated into existing viable cells. In other words, the cells that persist over time show an
ability to utilize energy in forms that were not necessary for initial growth in a closed system.
After studying the expression of genes whose products could differentiate between aerobiosis
and anaerobiosis, an attempt was made to support the observations from the first set of
experiments by quantifying expression of the same genes directly in sputum. It was hoped that
we could measure gene expression normalized for the number of organisms present in the
specimen. However, this could not be achieved since there was hardly any 16s RNA detectable.
This is likely on the account of inhibition of the reversed transcriptase PCR reaction by
inhibitors in the sputum. Despite these inhibitors, there were relatively large amounts of fdxA,
frdA and menB. This supports the findings of the culture based experiments that the lungs of
patients with pulmonary tuberculosis harbour large amounts of mycobacterial cells in the
anaerobic metabolic mode. The low 16S transcripts may imply the presence of nonreplicating
bacilli.
Measuring gene expression of M. tuberculosis in sputum can be used as a proxy for bacterial
load. Therefore, such tests can be used to measure response to treatment if this is done in
consecutive specimens of patients on anti-TB treatment. This has potential application in
molecular diagnostics.
We found large variations in the quantities of RNA per microlitre in sputum. The total RNA
measured is a combination of RNA from host cells and from bacteria. Since these specimens
were decontaminated, it is not likely that contaminating organisms contributed to the quantities
noted. Differences in the number of inflammatory cells, i.e. host factors, could account for the
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differences in total RNA, In addition, the alkaline environment created by the decontamination
process could also destroy RNA in an un-standardised way. The conversion of RNA to cDNA
from the same amount of RNA was also erratic. Sputum is rich in highly glycosolated protein
mucin and such molecules have been identified as potent PCR inhibitors. The amount of mucus
present in sputum specimens varies between patients and between specimens obtained from the
same patient. Despite the decontamination and the presence of inhibitors, we were still able to
detect transcription products of all the genes looked for directly in sputum specimens.
Our results indicate that the “dormancy” achieved in the oxygen depletion model equates
anaerobic metabolism likely in combination with a low level of multiplication. The question
remains whether this is also the case in vivo. Since the redox potential in human tissue and on
mucosal surfaces is too low to allow oxidative processes, facultative bacterial species largely
would have to apply anaerobic metabolism while in the human host. This might also be the case
with M. tuberculosis. The dormant state during latent infection however, might be different
from this.
Cunningham and Spreadbury (1998) showed that there is a thickening of the cell wall under
anaerobic conditions. Perhaps this is due to the over expression of electron transport
components as demonstrated in our in vitro study. Although depletion of free oxygen occurs in
liquid cultures, oxygen is always present due to the molecular structure of the water molecule.
This oxygen can always become available through enzymatic hydrolysis. However, the
resulting release of protons will affect the redox potential in the immediate vicinity of the cells
and this interferes with the transfer of electrons to oxygen.
112
Further studies with organisms grown under strict anaerobic conditions are warranted. Studies
using the Wayne model should incubate for a prolonged period of time.
In summary, all three components of this study support the facultative nature of M. tuberculosis.
It raises the important question whether dormancy in M. tuberculosis in vivo is real dormancy in
which the organism stops its metabolism or a change to anaerobiosis which is combined with a
slow multiplication rate. If the latter is true, we will likely be able to find or design drugs that
are able to eradicate these “dormant” organisms. In addition the work presented here forms the
basis of a potential application in molecular diagnostics for drug efficiency, where multiple
markers can be used to track bacterial loading in specimens.
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Classical Culture: Serial Dilution of Specimens
Figure A1: Serial dilution schematic and 10ml screw-cap tube showing growth in
Middlebrook 7H9 Liquid media
1. Classical Culture techniques
1.1. 10-fold serial dilution of homogenized sputum specimens.
1.1.1. Add 1ml of homogenized sputum to 9ml of PBS
1.1.2. Pipette repeatedly with gentle action to prevent aerosol formation, but
enough to ensure homogeneity of the media and sputum.
1.1.3. Have the number of required tubes for the dilution series prepared with
9ml media.
1.1.4. Add 1ml of sputum mixture to the next tube in the dilution series.
1.1.5. Mix as directed in 1.1.2.
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1.1.6. Repeat serial dilution to the level required for the experiment.
1.1.7. Label caps with permanent ink.
1.1.8. 10-fold dilutions can be made as follows according to different
experimental requirements
1.1.8.1. 1ml of sample into 9ml of media
1.1.8.2. 0.5ml sample into 4.5ml media
1.1.8.3. 2ml sample into 18ml of media
1.2. MEDIA PREPARATION
1.2.1.1. Middlebrook 7H9 liquid media (From Internal Protocols Dept
Medical Microbiology)
1.2.1.2. Middlebrook 7H9 dehydrated media (Difco, USA) [9.14g]
 Distilled water [1800ml]
 Glycerol [4ml]
 Suspend dry ingredients in distilled water. Add Glycerol
 Autoclave at 121OC for 15 minutes
 Allow to cool in a water bath to 60OC
 Aseptically add 200ml of OADC (Difco) supplement




 Amphotericin B 0,01
 Polymyxin B 200,000 units
 Aseptically dispense liquid media into tubes as required.
1.2.1.3. Middlebrook 7H11 Agar. (From Internal Protocols Dept Medical
Microbiology)
 Middlebrook 7H11 Agar (Difco, USA) [42g]
 Casitone [2g]
 L-Asparagine Monohydrate [10g]
 Glycerol [10ml]
 Distilled Water [1800ml]
 Suspend dry ingredients in distilled water. Add Glycerol
 Autoclave at 121OC for 15 minutes
 Allow to cool in a water bath to 60oC
 Aseptically add 200ml of OADC (Difco) supplement
 Add antibiotics as indicated for MB7H9 above
 Aseptically dispense agar into plates as required and aliquots of liquid media into
sterile tubes as required.
 Take note of manufactures instructions at all times, and between batches.
141
2. Primer and Probe Design
2.1. Download gene sequences from 3 databases
2.2. Checked for conserved regions in Genedoc The figures below show an example
based on the 16s ribosomal rna geme sequence. Random “x’s” were used to
replace certain bases for illustrative purposes. The software highlight where the
sequences do not align (grey coloration) emphasized with red rings’
2.3. Chose a region of the gene where there is complete congruence between the
sequences.
2.4. Upload that gene segment into Primer Express Software.
2.5. Run the Automatic Primer and Probe search.
2.6. A list of primer and probe combinations will be generated and listed from
highest ranking to lowest.
2.7. The higher the ranking (ie lower penalty score) the better the primer and probe
combination.
2.8. High penalties are of significance in the event that you plan to run multiplex
PCR
2.9. It is not recommended that you run Multiplex PCR on genes that you are testing
for the first time.
2.10. If you want the sequence design to be outsourced, you still need to pick a
region for the probe.
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2.11. Choose an area in the gene segment where the top 10 probes are located.
Once your primer and probes are received – ensure that they are aliquoted into
smaller volumes to avoid unnecessary freezing and thawing.
2.12. If a different PCR system is to be employed, ensure that primers and
probes are designed for optimal use on that particular system. This is particularly
important for genes that have not been studied before,or tested under novel
experimental conditions.
2.13. .
Figure A2.1 Screen Capture of GeneDoc with 16S rrs gene sequences from different
databases
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Figure A2.2 Screen capture of GeneDoc software with 16S gene sequence alignment and
deliberate “x”s added in to illustrate highlighting of unconserved regions
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3. RNA Isolation from H37Rv
3.1. Prepare culture tubes by inoculating log phase cells into liquid culture. Prepare
sufficient tubes for experimental replicates as well as extra tubes for use in
optical density determination.
3.2. If a time series is involved, inoculate extra tubes for the early time points to
increase the yield if necessary. (To convert OD600 to cell number use the
conversion of 3 x107 cells/ml for OD600 = 1)
3.3. Centrifuge cultures at 4500xg for 40 minutes (the supernatant must be visually
clear of all floccules, repeat centrifugation if necessary to ensure that all
floccules have pelleted.)
3.4. Aspirate media using a 1ml pipette
3.5. Add 0.5ml Trizol to each pellet and mix by repeated pippetting (if the pellet
does not completely dissolve, split the mixture and treat as two samples, then
pool the RNA at the end to ensure a cleaner product)
3.6. Transfer bacterial culture to a pre-chilled microcentrifuge tube containing
300µg glass beads (150-220µm) (it is better to use 2ml tubes for the initial
stages instead of 1.5ml tubes)
3.7. Vortex tubes 5 times for 30 seconds at a time.
(Initially, Microscopically analyse lysates for verification of cell disruption
(Ziehl Neelsen Staining Technique)
3.8. Incubate at room temperature for 5 minutes.
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3.9. Add 0.1 ml cold chloroform and mix by shaking the tube vigorously by hand
for 15 seconds.
3.10. Incubate at room temperature for 2-3 minutes.
3.11. Centrifuge the samples at 12,000 x g for 15 minutes at 4°C.
3.12. Transfer ~400 µl of the colourless, upper phase containing RNA to a fresh
tube. DO NOT let the pipette tip come into contact with the opaque layer
separating the organic and aqueous phases (It is better to use a 1.5ml tube with a
pointed bottom to reduce the surface area for the RNA and therefore improve
the dissolution process).
3.13. To remove any contaminating gDNA use DNAse 1 as follows
i. To aqueous phase in clean tube, add:
1. 10x Reaction buffer with MgCl2 : 10µl
2. DNAse 1 (1U/µl) : 10µl
ii. Incubate at 37OC for 60 minutes
iii. Add 5µl EDTA and incubate for 15 minutes at 65OC to inactivate
DNAse Activity.
(It is better to use a dry heat method eg heating block instead of a
water bath to reduce the risk of cross contamination)
3.14. Add 0.4 ml cold isopropanol to the aqueous phase to precipitate RNA. Mix
by inverting the tube.
3.15. Incubate at room temperature for 10 minutes.
3.16. Centrifuge at 15,000 x g for 10 minutes at 4°C.
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3.17. Remove the supernatant carefully without disturbing the RNA pellet
3.18. Resuspend the pellet in 0.8 ml 75% ethanol. Mix well by vigorously shaking
by hand for 15 seconds.
3.19. Centrifuge at 7,500 x g for 5 minutes at 4°C.
3.20. Aspirate the ethanol carefully and allow all traces of ethanol to evaporate,
i.e.: Air-dry the RNA pellet.
3.21. Resuspend the RNA pellet in 30µl DEPC treated water
3.22. Dissolve the RNA pellet by heating at 60-65OC for 10 minutes (The
importance of this is shown by Nanodrop evaluation as shown below in figure 1
3.23. Store RNA immediately at -80OC
Figure A3. Nanodrop-1000 readings for RNA dissolved at 55oC (A) and the same sample
after heating at 65oC (B)
A B
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4. REVERSE TRANSCRIPTION USING THE HIGH CAPACITY CDNA
ARCHIVE KIT
4.1. Allow the kit components to thaw on ice
4.2. It is useful to aliquot each solution into sterile nuclease free tubes. This reduces
the number of freeze-thaw cycles that the components undergo. Aliquot
volumes should be enough to supply for an entire experiment with 2 reactions
to spare.








10X Random Primers 10
50U/ml Reverse Transcriptase 5
Nuclease free H20 21
Total volume 50
4.4. Add 50µl of Master mix to 50µl of RNA in a 200µl PCR tube
4.5. Briefly spin tubes to eliminate air bubbles
4.6. Place tubes in a GeneAmp 9700 Thermal Cycler (Applied Biosystems)
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4.7. Run the reverse transcription cycle under the following conditions which are
optimized for use with this kit at 100µl reaction volume
Step (1) 25OC 10 minutes:
Step (2) 37OC 120 minutes
4.8. cDNA should be stored at -80OC for long term. cDNA is more stable than
RNA, therefore one should minimize the time between RNA extraction and
cDNA conversion and store cDNA rather than RNA for long term use.
4.9. Although it is not essential, it is useful to determine the quantities of cDNA
usinghte Nanodrop system as this will indicate if there was inhibition or failure
of any kit components during the conversion process.
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5. DETERMINING QUANTITY OF DNA FOR STANDARD CURVE
It is a standard practice in gene expression assays to use genomic DNA to establish a
standard curve. The following description of establishing such a standard curve is
based on an in-house method for the extraction of DNA and the formula derivation of
quantities was obtained through Applied Biosystems Technical Literature.
The standard curve will be established based on the number of gene copies and mass
of the genome of M. tuberculosis. The genome size for any organism can be obtained
from the following website:
http://www.cbs.dtu.dk/databases/DOGS/index.html
The following formula was used to calculate the mass of the genome
150.
151.
Based on the mass of the DNA and genome size the number of gene copies can be derived for a
specific volume of sample using the standard volume/concentration formula
FORMULA 1
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The volume loaded into each of the reactions of gDNA for the PCR is 11.25µl. Using the
formula above and genome information from the above named website – it was determined that
the volume of 100µl containing 333333 gene copies will require a concentration of 1.6µg.
Quantitation parameters for the standard curve will be determined using Formula 2 indicated
above.




Since it is nearly impossible to measure DNA of such a minute quantity, one obtains a mass of
DNA and uses the ratio of DNA to gene copy number to determine the values of the standard
curve. Using basic ratio and proportion, one can determine the number of gene copies per mg
of DNA using the ratio of 1 gene copy: 0.0047pg as determined in the calculation shown above.
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6. DNA EXTRACTION FOR STANDARD CURVE
6.1. Aliquots of 30 ml of MB7H9 culture were added to 50ml Sterilin centriguge
tubes.
6.2. Mycobacterial cells were pelleted by centrifugation for 30mins at 3000xg.
6.3. The media was carefully removed by aspiration without disturbibg the pellet
6.4. The pellet was then re-suspended in 2ml of 1xTE buffer.
6.5. 500 µL aliquots were transferred to a 2ml Eppendorf tube.
6.6. The cells were heat treated for 20 minutes at 95OC in a water bath.
6.7. The cells were vortexed for 30 seconds
6.8. Tubes were left on the bench at room temperature for 3 minutes to allow the
beads to settle.
6.9. The supernatant was transferred to sterile Eppendorf tubes.
6.10. 50µl of 10mg/ml lysozyme was added to each tube.
6.11. The tubes were incubated in a water bath for 60mins at 37OC.
6.12. 75 µl Proteinase K / 10% SDS solution was added
6.13. The tubes were incubated for 20 minutes in a water bath at 65OC.
6.14. 50µl of RNAse (DNAse-free) molecular grade (Fermentas) was added
6.15. The tubes incubated at room temperature for 20 minutes.
6.16. 300µl 5M NaCl was added along with 300µl of prewarmed (65OC)
CTAB/NaCl.
6.17. The tubes were vortexed for 15 seconds and incubated in a waterbath for 30
minutes at 65OC.
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6.18. Thereafter 750µl of Chloroform/Isoamyl Alcohol (in a 24:1 ratio) was added
and vortexed.
6.19. The tubes were then centrifuged for 20 minutes at 12000g.
6.20. The tubes after centrifugation presented 2 distinct phases separated by a
creamy interphase that had a fatty texture.
6.21. The upper phase was transferred to a sterile 1.5ml Eppendorf tube using a
200µl pipette.
6.22. 500µl of chilled isopropanol was added
6.23. Tubes were incubated overnight at -20OC to allow the DNA to precipitate.
6.24. The DNA was pelleted by centrifugation for 20 minutes at 12000g.
6.25. The isopropanol was carefully removed from the tubes without disturbing the
pellet.
6.26. The pellet was washed 3x by adding 1ml of chilled 70% ethanol followed by
centrifugation for 20 minutes at 12000xg.
6.27. The ethanol was removed by aspiration followed by air drying.
6.28. The pellet was re-suspendend in 40µl of 1XTE buffer.
6.29. The DNA was allowed to dissolve overnight at 4OC.
6.30. DNA samples were pooled into a single tube and the concentration was then
determined using the NANODROP 1000.
6.31. The following figures illustrate quantities from an extraction and
corresponding graphical output from the Nanodrop-1000 as well as genomic
DNA visualized by electrphoresis in 2% agarose.
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Figure A6.1: Screen Capture of genomic DNA quantitation data from Nanodrop 1000
Figure A6.2: DNA in agarose gel
 Once a stock solution of DNA is established, it is essential to split the DNA solution
into sinlge use aliquots, to avoid the freeze/thaw cycles on the same tube. This will
contribute to the degradation of nucleic acids and affect the quantification.
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7. PCR
The real-time PCR will be carried out in 96-well optical reaction plates designed for the ABI
Prism 7000 sequence detection system. The genes of interest will be investigated in triplicate
for each time point and in three separate runs. The software determines the gene copy numbers
for each gene and these results will be normalized against the 16S RNA gene copy numbers at
each respective time point. This is a standard practice in gene expression assays. The number of
16S copies is thought to represent the number of cells present at the time of the extraction. This
serves to neutralize any effects of inconsistency that may be present in cell numbers at the time
of extraction.
7.1 Relative Quantitation and Analysis of Raw Data
The ABI 7000SDS equipment gives a comprehensive report of each real-time PCR in each run
including gene copy number of each respective gene. The gene copy numbers were divided by
the copy number of the 16S rRNA gene obtained at each corresponding time point to give the
normalized gene expression ratio. These normalized ratios were then graphically represented to
establish the trends in gene expression.
The explanations given are based on the training which we received on-site for operation of the
ABI7000SDS. The certified copy of the certificate of competence is attached (Appendix A) The
ABI system generates a standard curve based on quantities that are provided by the user. The
parameters of a good standard curve lie in the slope which determines the PCR efficiency and
the R2 values that should be as close to one as possible.
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Figure A7.1 System Generated Standard Curve from a typical Run
The standard curve above is system generated and has a slope of -3.37 with an R2 value of 0.99.
This is a high quality standard curve and is more cumbersome to establish then it appears. The
Taqman probes are extremely sensitive and will detect the slightest inconsistencies in pippetting
technique.
The system also generates spectral data graphically to show the progression of the reaction. The
following graphs represent spectral graphs at the beginning and end of the run. The 7000SDS
has 4 filters that are able to filter signals at different frequencies. We use MGB probes that are
labeled with FAM and a non-fluorescent quencher (NFQ) The signal of FAM is detected by
filter A. The figures below indicate an increase in fluorescence over the duration of the PCR.
Each line represents a single well. The lines with the highest signal are the wells with the
highest template copies. Evaluating these graphs in the software can tell you whether the copy
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numbers were too high, as you can see the progression of the signal for each cycle. If the copy
numbers are too high the dye will peak early and then decrease towards the end. This type of
data can also indicate whether the probes were not functional. Although it is not within the
scope of this project, this type of data can be useful for fine examination of multiplex PCR as
well.
Figure A7.2 a&b: Raw Fluorescence Signal reporting at the start and end of a run
The software also generates scatter plot graphs that show the threshold cycle relative to the well
positions in plates. When reactions are conducted in triplicate, one can track how close the
readings are based on the pattern formed. It is also useful when looking at the standard curve as
you can easily spot outliers if they are present.
A B
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Figure A7.3 a&b: Scatter plot based on threshold cycles for a typical run of samples in
triplicate and the corresponding standard curve
here are also component graphs that show the pattern of the dye in each well relative to the
background dye that is present in the master mix. These graphs show the threshold cycle per
well. The example below shows the first graph of a sample with a much higher target template
than the second one. The higher the template the earlier the threshold cycle appears. This type
of graph is useful for analysis and is available for each well. It also shows the distinctly





Figure A7.4 a&b: Component fluorescence data for individual wells with a high and low
target template respectively
In the case of the negative control, the FAM (indicated as red in the figure) should be below that
of the background dye ROX (indicated as blue in the figure) as shown below
Figure A7.5: Typical fluorescence data for Non Template (Negative) Control
Finally there are the typical sigmoidal amplification curves that show the signal of the reporter
dye over the duration of the PCR. These graphs can be used to view multiple wells. In the case
of the standard curve, the signals should be approximately equally spaced. Negative signals are
normally below the baseline. Signals that just start to increase in strength towards the end of the
PCR are also considered negative. The first graph below is the corresponding amplification plot
for the standard curve shown above. The other sigmoidal curves represent signals for all the
wells in the plate. The negative controls are seen as virtually horizontal just above the X-axis.
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8. Statistical Analysis : Definitions
Statistical definitions below are quoted directly from the websites indicated
Mann-Whitney U test is the alternative test to the t-test. Mann-Whitney U test is a
non-parametric test that is used to compare two population means that come from the
same population. Mann-Whitney U test is also used to test whether two population
means are equal or not. Mann-Whitney U test was developed by Wilcoxon in 1945. It
is used for equal sample sizes, and is used to test the median of two populations
http://www.statisticssolutions.com/methods-chapter/statistical-tests/mann-whitney-u-
test/
One way Analysis of Variance (ANOVA) is a statistical technique that is used to
compare the means of more than two groups. A detailed explanation is available at this
site:
http://www.statisticssolutions.com/methods-chapter/statistical-tests/one-way-anova/
F-test: F-statistics is used to compare the means in one way ANOVA. F-statistics is the
ratio of MS between the group variance and MS within the group variance.
http://www.statisticssolutions.com/methods-chapter/statistical-tests/one-way-anova/
The F-test in one-way analysis of variance is used to assess whether the expected values
of a quantitative variable within several pre-defined groups differ from each other.
An F-test is any statistical test in which the test statistic has an F-distribution under the
null hypothesis. It is most often used when comparing statistical models that have been
162
fit to a data set, in order to identify the model that best fits the population from which
the data were sampled. Exact F-tests mainly arise when the models have been fit to the
data using least squares. The name was coined by George W. Snedecor, in honor of Sir
Ronald A. Fisher. Fisher initially developed the statistic as the variance ratio in the
1920s (Lomax, Richard G. (2007) "Statistical Concepts: A Second Course", p. 10
In statistics, the Kruskal–Wallis one-way analysis of variance by ranks (named after
William Kruskal and W. Allen Wallis) is a non-parametric method for testing equality
of population medians among groups. It is identical to a one-way analysis of variance
with the data replaced by their ranks. It is an extension of the Mann–Whitney U test to 3
or more groups. Since it is a non-parametric method, the Kruskal–Wallis test does not
assume a normal population, unlike the analogous one-way analysis of variance.
However, the test does assume an identically-shaped and scaled distribution for each
group, except for any difference in medians. Siegel and Castellan. (1988).
"Nonparametric Statistics for the Behavioral Sciences" (second edition). New York:
McGraw–Hill
Both the Tukey test (also called Tukey-Kramer test) and the Newman-Keuls (also
called Student-Newman-Keuls test) are used to compare all pairs of means following
one-way ANOVA. Although these are called post tests, they can be performed
regardless of the results of the overall ANOVA results.
The Newman-Keuls test has more power. This means it can find that a difference
between two groups is 'statistically significant' in some cases where the Tukey test
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would conclude that the difference is 'not statistically significant'. But this extra power
comes at a price. Although the whole point of multiple comparison post tests is to
keep the chance of a Type I error in any comparison to be 5%, in fact the Newman-
Keuls test doesn't do this1. In some cases, the chance of a Type I error can be greater
than 5%. Another problem is because the Newman-Keuls test works in a sequential
fashion, it can not produce 95% confidence intervals for each difference. Because the
Newman-Keuls test has two strikes against it (doesn't control error rate, doesn't
generate confidence intervals) we recommend that you use the Tukey test instead.
http://www.graphpad.com/faq/viewfaq.cfm?faq=1093
The Tukey–Kramer method is a single-step multiple comparison procedure and
statistical test generally used in conjunction with an ANOVA to find which means are
significantly different from one another. Named after John Tukey, it compares all
possible pairs of means, and is based on a studentized range distribution q (this
distribution is similar to the distribution of t from the t-test
The test compares the means of every treatment to the means of every other treatment;
that is, it applies simultaneously to the set of all pair wise comparisons
(Linton, L.R., Harder, L.D. (2007) Biology 315 – Quantitative Biology Lecture Notes.
University of Calgary, Calgary, AB) The Student Newman–Keuls and related tests are
often referred to as post hoc
Post-hoc analysis, in the context of design and analysis of experiments, refers to
looking at the data—after the experiment has concluded—for patterns that were not
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specified a priori. It is sometimes called by critics data dredging to evoke the sense that
the more one looks the more likely something will be found. More subtly, each time a
pattern in the data is considered, a statistical test is effectively performed. This greatly
inflates the total number of statistical tests and necessitates the use of multiple testing
procedures to compensate. However, this is difficult to do precisely and in fact most
results of post-hoc analyses are reported as they are with unadjusted p-values. These p-
values must be interpreted in light of the fact that they are a small and selected subset of
a potentially large group of p-values. Results of post-hoc analysis should be explicitly
labeled as such in reports and publications to avoid misleading readers.
Bartlett’s test for homogeneity of variance in statistics, a test to ascertain if multiple
samples have the same variance (the square of the sample’s standard deviation). The
test, which is a standard tool in analysis of variance (ANOVA) computer programs, can
be used when a single measurable variable is involved, such as when testing the efficacy
of a new drug. The test was introduced by the English statistician Maurice Stevenson
Bartlett in 1937
http://www.britannica.com/EBchecked/topic/1508940/Bartletts-test
Bartlett's test ( Snedecor and Cochran, 1983) is used to test if k samples have equal
variances. Equal variances across samples are called homogeneity of variances. Some
statistical tests, for example the analysis of variance, assume that variances are equal
across groups or samples. The Bartlett test can be used to verify that assumption.
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Bartlett's test is sensitive to departures from normality. That is, if your samples come




All statistical procedures have underlying assumptions. In some cases, violation of these
assumptions will not change substantive research conclusions. In other cases, violation
of assumptions is critical to meaningful research. All forms of statistical analysis assume
sound measurement, relatively free of coding errors. It is good practice to run
descriptive statistics on one's data so that one is confident that data are generally as
expected in terms of means and standard deviations, and there are no out-of-bounds
entries beyond the expected range.
http://faculty.chass.ncsu.edu/garson/PA765/assumpt.htm
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